<SEC-DOCUMENT>0001193125-24-272928.txt : 20241209
<SEC-HEADER>0001193125-24-272928.hdr.sgml : 20241209
<ACCEPTANCE-DATETIME>20241209081129
ACCESSION NUMBER:		0001193125-24-272928
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20241209
DATE AS OF CHANGE:		20241209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WOLFSPEED, INC.
		CENTRAL INDEX KEY:			0000895419
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				561572719
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283676
		FILM NUMBER:		241533915

	BUSINESS ADDRESS:	
		STREET 1:		4600 SILICON DR
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
		BUSINESS PHONE:		9194075300

	MAIL ADDRESS:	
		STREET 1:		4600 SILICON DR
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703-8475

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CREE, INC.
		DATE OF NAME CHANGE:	20190808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CREE INC
		DATE OF NAME CHANGE:	20000103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CREE RESEARCH INC /NC/
		DATE OF NAME CHANGE:	19940224
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d840767d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(5)<BR>Registration Statement No. 333-283676 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement to Prospectus dated December&nbsp;9, 2024. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Up to $200,000,000 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g840767g24g51.jpg" ALT="LOGO" STYLE="width:1.40997in;height:0.45485in;">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B><I>Common Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">On December&nbsp;9, 2024, we entered into an equity distribution agreement (the &#147;Distribution Agreement&#148;) with J.P.&nbsp;Morgan Securities LLC and
Wells Fargo Securities, LLC (each, a &#147;Manager&#148; and, collectively, the &#147;Managers&#148;), providing for the offer and sale of shares of our common stock having an aggregate gross sales price of up to $200,000,000 from time to time
through the Managers, acting as our agents, or directly to the Managers, acting as principals. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">Sales of shares of our common stock, if any, under this
prospectus supplement and the accompanying prospectus may be made (1)&nbsp;in &#147;at the market&#148; offerings (as defined in Rule 415 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;)) by means of ordinary
brokers&#146; transactions at market prices prevailing at the time of sale, including sales made on the New York Stock Exchange (the &#147;NYSE&#148;), sales made to or through market makers and sales made through other securities exchange or
electronic communications networks, and (2)&nbsp;in such privately negotiated transactions, which may include block trades, as we and any Manager may agree. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">We will pay the applicable Manager a commission equal to (except as provided below) up to 3.0% of the gross sales price per share of our common stock sold
through such Manager, as our agent, under the Distribution Agreement. We may also agree with any agent to sell shares of our common stock other than through ordinary brokers&#146; transactions using sales efforts and methods that may constitute
&#147;distributions&#148; within the meaning of Rule 100 of Regulation M under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), and for which we may agree to pay such agent a commission that may exceed 3.0% of the
gross sales price per share of our common stock sold. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">None of the Managers is required to sell any specific number or dollar amount of shares of our
common stock but each has agreed to use its commercially reasonable efforts to sell, on the terms and subject to the conditions of the Distribution Agreement, shares of our common stock on terms agreed upon by us and such Manager from time to time.
The shares of our common stock offered and sold through the Managers, as our agents, pursuant to the Distribution Agreement will be offered and sold through only one Manager on any given day. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">Under the terms of the Distribution Agreement, we may also sell shares of our common stock to one or more of the Managers as principal, at a price per share
to be agreed upon at the time of sale. If we sell shares to one or more of the Managers as principal, we will enter into a separate terms agreement with such Manager or Managers, as the case may be, and we will describe the terms of the offering of
those shares in a separate prospectus supplement. In any such sale to a Manager as principal, we may agree to pay the applicable Manager a commission or discount that may exceed 3.0% of the gross sales price per share of common stock sold to such
Manager, as principal. The offering of our common stock pursuant to the Distribution Agreement will terminate upon the earlier of (1)&nbsp;the sale of all of the common stock subject to the Distribution Agreement and (2)&nbsp;the termination of the
Distribution Agreement by either the Managers or us. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">Our common stock is listed on the NYSE under the symbol &#147;WOLF.&#148; On December&nbsp;6, 2024,
the last reported sale price of our common stock on the NYSE was $9.45 per share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11.5pt; font-family:Times New Roman"><I>An investment in our common stock involves risk. See &#147;<A HREF="#supptoc840767_5">Risk&nbsp;Factors</A>&#148; beginning on <FONT STYLE="white-space:nowrap">page&nbsp;S-7</FONT> of this prospectus supplement and in our most recent Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> and our Quarterly Reports on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> filed with the Securities and Exchange Commission to read about important factors that you should consider before investing in our common stock. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the
accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:14pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="56%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:14pt">
<TD VALIGN="top"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>Wells&nbsp;Fargo&nbsp;Securities</B></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="center"><B>December&nbsp;9, 2024 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_1">About this Prospectus Supplement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_2">Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_3">Prospectus Supplement Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_4">The Offering</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_5">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_6">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_7">Dividend Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_8">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_9">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_10">Material U.S. Federal Income Tax Consequences to <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_11">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-20</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_12">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-20</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_13">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-21</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc840767_14">Incorporation of Certain Information by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_1">About this Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_2">Special Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_3">Where You Can Find More Information; Incorporation by
Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_4">The Company</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_5">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_6">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_7">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_8">Description of Debt Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_9">Description of Other Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_10">Global Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_11">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_12">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_13">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read this prospectus supplement, the accompanying prospectus, the documents incorporated by reference in this prospectus supplement and the
accompanying prospectus, and any free writing prospectus that we have authorized for use in connection with this offering when making your investment decision. You should also read and consider the information in the documents we have referred you
to in the section of this prospectus supplement entitled &#147;Where You Can Find More Information.&#148; This prospectus supplement and the accompanying prospectus are part of a registration statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT> we have filed with the Securities and Exchange Commission (the &#147;SEC&#148;), under the Securities Act. This prospectus supplement and the accompanying prospectus do not contain all of the information
in the registration statement. We have omitted certain parts of the registration statement, as permitted by the rules and regulations of the SEC. You may find the registration statement, including exhibits, on the SEC&#146;s website at www.sec.gov.
See &#147;Where You Can Find More Information; Incorporation by Reference&#148; in the accompanying prospectus. In addition, any statement in a filing we make with the SEC that adds to, updates or changes information contained in an earlier filing
we made with the SEC shall be deemed to modify and supersede such information in the earlier filing. Unless otherwise mentioned or unless the context requires otherwise, all references in this prospectus supplement to &#147;Wolfspeed,&#148;
&#147;we,&#148; &#147;us,&#148; &#147;our&#148; or similar references mean Wolfspeed, Inc. and its subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the information set forth in this
prospectus supplement differs in any way from the information set forth in the accompanying prospectus, you should rely on the information set forth in this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained or incorporated by reference in this prospectus supplement, the accompanying prospectus and any free writing
prospectus that we have authorized for use in connection with this offering. No dealer, salesperson or other person is authorized to give any information or to represent anything not contained or incorporated by reference herein or therein. If
anyone provides you with different or inconsistent information, you should not rely on it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not, and the Managers are not, making an offer to sell
the shares of our common stock in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus supplement, the accompanying prospectus, the documents incorporated by reference in this
prospectus supplement and the accompanying prospectus, and any free writing prospectus that we have authorized for use in connection with this offering is accurate only as of the date of those respective documents. Our business, financial condition,
results of operations, and prospects may have changed since that date. Neither this prospectus supplement nor the accompanying prospectus constitutes an offer, or an invitation on our behalf or on behalf of the Managers, to subscribe for and
purchase any of the securities, and may not be used for or in connection with an offer or solicitation by anyone, in any jurisdiction in which such an offer or solicitation is not authorized or to any person to whom it is unlawful to make such an
offer or solicitation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our logo and other trademarks mentioned in this prospectus supplement and the accompanying prospectus or any document incorporated
by reference herein are our property. Certain trademarks referred to in this prospectus supplement and the accompanying prospectus or any document incorporated by reference herein may be without the
<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> or TM symbol, as applicable, but this is not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our right to these trademarks. Other brand
names or trademarks appearing in this prospectus or any document incorporated by reference herein are the property of their respective owners. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_2"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement, the accompanying prospectus, the documents incorporated by reference and any free writing prospectus that we have authorized for
use in connection with this offering contain forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act. You can identify these statements by forward-looking words such as
&#147;may,&#148; &#147;will,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;anticipate,&#148; &#147;believe,&#148; &#147;estimate,&#148; &#147;plan,&#148; &#147;could,&#148; &#147;should,&#148; &#147;continue&#148; or the negative of such terms
or similar words or expressions. These forward-looking statements may also use different phrases. These forward-looking statements include, but are not limited to, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our future financial results; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">demand for products and applications using silicon carbide power devices and gallium nitride materials, including
the adoption of our products by electric vehicle manufacturers and the overall adoption of electric vehicles, and our ability to win new designs for these applications; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and amount of government incentives actually received, including, among other things, any direct
grants and tax credits under the CHIPS Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product and price competition in key markets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to lower costs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to balance fluctuations in customer demand and capacity, including bringing on additional capacity on
a timely basis to meet customer demand; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of global economic and geopolitical conditions, including uncertainty related to trade policy and
tariffs, the ongoing conflicts between Russia and Ukraine and in the Middle East, a slowdown of the economy in China, outbreaks of infectious diseases or similar public health events, the effect of inflation on product demand and costs, the
collectability of receivables and other related matters, including consumers and businesses deferring purchases or payments or defaulting on payment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of specific customers or countries on demand for our products or the concentration of our business
among a few customers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product mix; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans to invest in our business, including the construction of our new facility in North Carolina;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to <FONT STYLE="white-space:nowrap">ramp-up</FONT> production of our new products, and enter into new
business channels different from those in which we have historically operated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to meet targeted utilization rates at the Mohawk Valley Fab and our market growth;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to manage an increasingly complex supply chain that has the ability to supply a sufficient quantity
of raw materials, subsystems and finished products with the required specifications and quality; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of the RF Business Divestiture (as defined below) on our business, results of operations and financial
condition, as well as the performance by us and MACOM Technology Solutions Holdings, Inc. of obligations under various agreements related to the RF Business Divestiture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to protect our intellectual property, as well as to protect our confidential information from theft
or misuse, including through cyber-attacks or cyber intrusion; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to complete development and commercialization of products under development; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our evaluation of strategic opportunities, including acquisitions, divestitures, spin-offs, joint ventures or
investments in complementary businesses; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rapid development of new technology and competing products that may impair demand or render our products
obsolete; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential lack of customer acceptance for our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of interest rate fluctuations on our business; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assumptions relating to the foregoing. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements, which are
subject to risks, uncertainties and assumptions about us, may include, among other things, statements that address our strategy and operating performance and events or developments that we expect or anticipate will occur in the future, including,
but not limited to, our statements in &#147;Summary &#151; The Offering&#148; on page <FONT STYLE="white-space:nowrap">S-5</FONT> and &#147;Use of Proceeds&#148; on page <FONT STYLE="white-space:nowrap">S-10</FONT> regarding our intended use of the
proceeds of this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and
assumptions that are difficult to predict; therefore, actual results may differ materially from those expressed or forecasted in any forward-looking statements. The risks and uncertainties include those described in our most recent Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> and our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the SEC and in our subsequent filings under the Exchange Act as well as those referenced in &#147;Risk
Factors&#148; below. These are factors that we think could cause our actual results to differ materially from expected results. Other factors besides those listed could also adversely affect us. Any forward-looking statement speaks only as of the
date on which it is made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. New factors emerge from time to time, and it is not possible for us to
predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any
forward-looking statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_3"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information appearing elsewhere or incorporated by reference in this prospectus supplement and the accompanying prospectus
and any free writing prospectus that we have authorized for use in connection with this offering and may not contain all of the information that is important to you. This prospectus supplement and the accompanying prospectus include information
about the shares of common stock we are offering as well as information regarding our business and financial data. You should read this prospectus supplement and the accompanying prospectus, including information incorporated by reference, and any
free writing prospectus that we have authorized for use in connection with this offering, in their entirety. Investors should carefully consider the information set forth under &#147;Risk Factors&#148; in this prospectus supplement and in our most
recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the SEC, which are incorporated by reference into this prospectus supplement and the
accompanying prospectus. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Wolfspeed, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide materials and devices for power applications. Our product families
include power devices and silicon carbide and gallium nitride materials. Our products are targeted for various applications such as electric vehicles, fast charging and renewable energy and storage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our materials products and power devices are used in electric vehicles, motor drives, power supplies, solar and transportation applications. Our materials
products are also used in military communications, radar, satellite and telecommunication applications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During and prior to fiscal 2024, we designed,
manufactured and sold radio-frequency (&#147;RF&#148;) devices. We completed the sale of certain assets comprising our former RF product line (the &#147;RF Business Divestiture&#148;) in the second quarter of fiscal 2024. The RF Business Divestiture
represented a strategic shift that had a major effect on our operations and financial results. As a result, we have classified the results and cash flows of the RF product line as discontinued operations in our consolidated statements of operations
and consolidated statements of cash flows for all periods presented. Additionally, the related assets and liabilities associated with the transaction are classified as held for sale in the consolidated balance sheet as of June&nbsp;25, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The majority of our products are manufactured at our production facilities located in North Carolina, New York and Arkansas. We also use contract
manufacturers for certain products and aspects of product fabrication, assembly and packaging. We maintain captive lines at some of our contract manufacturers. We are constructing a new materials manufacturing facility in North Carolina. We operate
research and development facilities in North Carolina, Arkansas and New York. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wolfspeed, Inc. is a North Carolina corporation established in 1987, and our headquarters are in Durham, North Carolina. Our principal executive offices are
located at 4600 Silicon Drive, Durham, North Carolina 27703. Our telephone number is (919) <FONT STYLE="white-space:nowrap">407-5300.</FONT> Our website address is www.wolfspeed.com. The information on, or otherwise accessible through, our website
does not constitute a part of this prospectus supplement or the accompanying prospectus. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_4"></A>THE OFFERING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following is a brief summary of the terms of this offering and our common stock. This summary is not a complete description of this offering or our
common stock. You should read the full text and more specific details contained elsewhere in this prospectus supplement and the accompanying prospectus. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Issuer </P></TD>
<TD>Wolfspeed, Inc., a North Carolina corporation. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Securities Offered </P></TD>
<TD>Shares of our common stock with an aggregate gross sales price of up to $200,000,000. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common Stock to be Outstanding After this Offering </P></TD>
<TD>Up to 148,052,021 (as more fully described in the notes following this table), assuming sales of 21,164,021 shares of our common stock in this offering at an assumed offering price of $9.45 per share, which was the last reported sale price of
our common stock on the NYSE on December&nbsp;6, 2024. The actual number of shares issued will vary depending on the sales price under this offering. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Manner of Offering </P></TD>
<TD>&#147;At the market offering&#148; that may be made from time to time on the NYSE or other existing trading market for our common stock through the Managers. See the section entitled &#147;Plan of Distribution&#148; on <FONT
STYLE="white-space:nowrap">page&nbsp;S-14</FONT> of this prospectus supplement. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">NYSE Symbol for our Common Stock </P></TD>
<TD>Our common stock is listed on the NYSE under the symbol &#147;WOLF.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of Proceeds </P></TD>
<TD>We intend to use the net proceeds we receive from the issuance and sale by us of any shares of our common stock to or through the Managers for general corporate purposes, including capital expenditures. See &#147;Use of Proceeds&#148; on page <FONT
STYLE="white-space:nowrap">S-10.</FONT> </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk Factors </P></TD>
<TD>See &#147;Risk Factors&#148; on page <FONT STYLE="white-space:nowrap">S-7</FONT> and in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT>
filed with the SEC and any other information included or incorporated by reference in this prospectus supplement and the accompanying prospectus for a discussion of factors you should consider carefully before deciding to invest in shares of our
common stock. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares of common stock to be outstanding after the offering is based on 126,888,485 shares of common stock
outstanding as of September&nbsp;29, 2024, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,607,993 shares of common stock underlying restricted stock units and performance stock units outstanding as of
September&nbsp;29, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">43,932,947 shares of common stock issuable upon conversion of outstanding convertible notes as of
September&nbsp;29, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><A NAME="suppcov840767_4"></A>&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">up to an aggregate of 2,099,579 shares of common stock available for future grant under our 2023 Long-Term
Incentive Compensation Plan as of September&nbsp;29, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">up to an aggregate of 4,161,300 shares of common stock available for future grant under our 2020 Employee Stock
Purchase Plan as of September&nbsp;29, 2024; and </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">up to an aggregate of 37,684 shares of common stock available for future grant under our <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director Stock Compensation and Deferral Program as of September&nbsp;29, 2024. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
addition, unless we specifically state otherwise, all information in this prospectus supplement reflects and assumes no vesting of the outstanding restricted stock units and performance stock units and no conversion of the outstanding convertible
notes described above. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investing in the shares of common stock being offered by this prospectus supplement and the accompanying prospectus involves a high degree of risk. Before
deciding whether to invest in our common stock, you should consider carefully the risk factors described below, the risk factors incorporated herein by reference to our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT>
and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the SEC and the risk factors contained in any free writing prospectus that we have authorized for use in connection with this offering. If any of these risks
actually occur, it may materially harm our business, financial condition, operating results or cash flow. As a result, the market price of our common stock could decline, and you could lose part or all of your investment. Additional risks and
uncertainties that are not yet identified or that we think are immaterial may also materially harm our business, operating results and financial condition and could result in a complete loss of your investment</I>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to our Common Stock and this Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may invest or spend the proceeds of this offering in ways with which you may not agree and in ways that may not yield a return to our shareholders.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will retain broad discretion over the use of proceeds from this public offering. Shareholders may not deem such uses desirable, and our use of
the proceeds may not yield a significant return or any return at all for our shareholders. We intend to use the net proceeds we receive from the issuance and sale by us of any shares of our common stock to or through the Managers for general
corporate purposes, including capital expenditures. Because of the number and variability of factors that determine our use of the proceeds, our actual uses of the proceeds may vary substantially from our currently planned uses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future sales or issuances of our common stock in the public markets, or the perception of such sales, could depress the trading price of our common
stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The sale of a substantial number of shares of our common stock or other equity-related securities in the public markets, or the perception
that such sales could occur, could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. We may sell large quantities of our common stock at any time pursuant to this
prospectus supplement or in one or more separate offerings. We cannot predict the effect that future sales of common stock or other equity-related securities would have on the market price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>You may experience immediate and substantial dilution as a result of this offering. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offering price per share of our common stock in this offering may exceed the net tangible book value per share of our common stock outstanding prior to
this offering. Assuming that an aggregate of 21,164,021 shares of our common stock are sold in this offering, based on an assumed sale price of $9.45 per share, the last reported sale price of our common stock on the NYSE on December&nbsp;6, 2024,
for aggregate gross proceeds of $200&nbsp;million, and, after deducting commissions and estimated offering expenses payable by us, you will experience immediate dilution of $6.48 per share, representing the difference between the price you pay and
our as adjusted net tangible book value per share as of September&nbsp;29, 2024, after giving effect to this offering, and the assumed public offering price. The issuance of shares of common stock in connection with the vesting of restricted stock
units or the issuance of shares of common stock pursuant to the conversion of outstanding convertible notes may result in further dilution of your investment. See the section titled &#147;Dilution&#148; below for a more detailed illustration of the
dilution you may incur if you participate in this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our stock price may be volatile. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Historically, our common stock has experienced substantial price volatility, particularly as a result of significant fluctuations in our revenue, earnings and
margins over the past few years, and variations between our actual </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financial results and the published expectations of analysts. For example, the closing price per share of our common stock on NYSE ranged from a low of $6.44 to a high of $86.54 during the period
from January&nbsp;1, 2023 to December&nbsp;6, 2024. If our future operating results or margins are below the expectations of stock market analysts or our investors, our stock price will likely decline. Speculation and opinions in the press or
investment community about our strategic position, financial condition, results of operations or significant transactions can also cause changes in our stock price. In particular, speculation on our <FONT STYLE="white-space:nowrap">go-forward</FONT>
strategy and competition in some of the markets we address such as electric vehicles, may have a dramatic effect on our stock price. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future sales
of our common stock by us or by our directors or officers could adversely affect the market price of our common stock and our ability to raise funds in a new securities offering. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue additional shares of common stock in subsequent public offerings or private placements. In addition, we may issue additional shares of common
stock upon conversion of our convertible notes, to our directors, officers and employees under our long-term incentive compensation plan, our employee stock purchase plan and our <FONT STYLE="white-space:nowrap">non-employee</FONT> director stock
compensation and deferral program, including upon the exercise of, or in respect of, distributions on equity awards previously granted thereunder. We are not required to offer any such shares to existing shareholders on a preemptive basis.
Therefore, it may not be possible for existing shareholders to participate in future share issuances, which may dilute existing shareholders&#146; interests in us. In addition, if market participants buy shares in issuances by us in the future, it
may reduce or eliminate any purchases of our common stock they might otherwise make in the open market, which in turn could have the effect of reducing the volume of shares of our common stock traded in the marketplace, which could reduce the market
price and liquidity of our common stock and, in turn, our ability to raise funds in a new securities offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain sales of shares of our common
stock by our current directors and officers who beneficially own our common stock are required to be publicly reported and are tracked by many market participants as a factor in making their own investment decisions. As a result, future sales by
these individuals could negatively affect the market price of our common stock and, in turn, our ability to raise funds in a new securities offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain of our outstanding securities rank, and we may in the future offer debt or equity securities that may rank, senior to our common stock, which
may adversely affect the market price of our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have issued senior notes and convertible notes, which have rights, preferences and
privileges more favorable than those of our common stock. If we decide to issue additional debt or preferred equity securities in the future, which would rank senior to our common stock, it is likely that they will be governed by an indenture or
other instrument containing covenants restricting our operating flexibility. Additionally, any equity securities or convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than
those of our common stock and may result in dilution to owners of our common stock. We and, indirectly, our shareholders, will bear the cost of issuing and servicing such securities. Because our decision to issue debt or equity securities in any
future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings. Thus, holders of our common stock will bear the risk of our future offerings
reducing the market price of our common stock and diluting the value of their stock holdings in us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The actual number of shares we will issue under
the Distribution Agreement, at any one time or in total, is uncertain. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to certain limitations in the sales agreement and compliance with
applicable law, we have the discretion to deliver a placement notice to the Managers at any time throughout the term of the Distribution Agreement. The number of shares that are sold by the Managers after delivering a placement notice will fluctuate
based on the market price of our common stock during the sales period and limits we set with the Managers. Because the price per share of each share sold will fluctuate based on the market price of our common stock during the sales period, it is not
possible at this stage to predict the number of shares that will be ultimately issued. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The common stock offered hereby will be sold in &#147;at the market offerings,&#148; and investors who
buy shares at different times will likely pay different prices. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors who purchase shares in this offering at different times will likely pay
different prices, and so may experience different outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold, and there is no minimum or maximum sales price.
Investors may experience a decline in the value of their shares as a result of share sales made at prices lower than the prices they paid. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We
currently do not plan to pay any cash dividends in the foreseeable future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have never paid cash dividends on our common stock and currently do
not plan to pay any cash dividends in the foreseeable future. Therefore, any return to shareholders will likely be limited to the appreciation of their common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds we receive from the issuance and sale by us of any shares of our common stock to or through the Managers for general
corporate purposes, including capital expenditures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_7"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have never paid cash dividends on our common stock and currently do not plan to pay any cash dividends in the foreseeable future. However, the declaration,
payment and amount of future dividends, if any, is subject to the discretion of our board of directors, which may review our dividend policy from time to time in light of the then existing relevant facts and circumstances. Our existing debt
instruments contain certain dividend distribution restrictions. Applicable state laws may also limit the payment of dividends. We may also be subject to additional dividend restrictions under future financing facilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_8"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our net tangible book value as of September&nbsp;29, 2024 was approximately $246.0&nbsp;million, or $1.94 per share. Net tangible book value per share is
determined by dividing our total tangible assets, less total liabilities, by the number of shares of our common stock outstanding as of September&nbsp;29, 2024. Dilution in net tangible book value per share represents the difference between the
amount per share paid by purchasers of shares of common stock in this offering and the as adjusted net tangible book value per share of our common stock immediately after giving effect to this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After giving effect to the assumed sale of our common stock in the aggregate amount of $200&nbsp;million in this offering at an assumed offering price of
$9.45, the last reported sale price of our common stock on the NYSE on December&nbsp;6, 2024, and after deducting commissions and estimated aggregate offering expenses payable by us, our as adjusted net tangible book value as of September&nbsp;29,
2024 would have been approximately $439.4&nbsp;million, or $2.97 per share. This represents an immediate increase in net tangible book value of $1.03 per share to existing shareholders and immediate dilution in net tangible book value of $6.48 per
share to new investors purchasing our common stock in this offering. The following table illustrates this dilution on a per share basis: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net tangible book value per share as of September&nbsp;29, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in net tangible book value per share attributable to new investors in this
offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">As adjusted net tangible book value per share as of September&nbsp;29, 2024 after this
offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors purchasing shares in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares sold in this offering, if any, will be sold from time to time at various prices. An increase of $1.00 per share in
the price at which the shares are sold from the assumed offering price of $9.45 per share shown in the table above, assuming all of our common stock in the aggregate amount of $200&nbsp;million is sold at that price, would increase our as adjusted
net tangible book value per share after the offering to $3.01 per share and would increase the dilution in net tangible book value per share to new investors to $7.44 per share, after deducting commissions and estimated aggregate offering expenses
payable by us. A decrease of $1.00 per share in the price at which the shares are sold from the assumed offering price of $9.45 per share shown in the table above, assuming all of our common stock in the aggregate amount of $200&nbsp;million is sold
at that price, would decrease our as adjusted net tangible book value per share after the offering to $2.92 per share and would decrease the dilution in net tangible book value per share to new investors to $5.53 per share, after deducting
commissions and estimated aggregate offering expenses payable by us. This information is supplied for illustrative purposes only. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that
outstanding restricted stock units vest, or outstanding convertible notes are converted, investors purchasing our common stock in this offering will experience further dilution. In addition, we may choose to raise additional capital due to market
conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of
these securities could result in further dilution to our shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The above discussion and table are based on 126,888,485 shares of our common stock
outstanding as of September&nbsp;29, 2024, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,607,993 shares of common stock underlying restricted stock units and performance stock units outstanding as of
September&nbsp;29, 2024; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">43,932,947 shares of common stock issuable upon conversion of outstanding convertible notes as of
September&nbsp;29, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">up to an aggregate of 2,099,579 shares of common stock available for future grant under our 2023 Long-Term
Incentive Compensation Plan as of September&nbsp;29, 2024; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">up to an aggregate of 4,161,300 shares of common stock available for future grant under our 2020 Employee Stock
Purchase Plan as of September&nbsp;29, 2024; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">up to an aggregate of 37,684 shares of common stock available for future grant under our <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director Stock Compensation and Deferral Program as of September&nbsp;29, 2024. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_9"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;9, 2024, we entered into the Distribution Agreement with the Managers providing for the offer and sale of shares of our common stock having
an aggregate gross sales price of up to $200,000,000 from time to time through the Managers, acting as our agents, or directly to the Managers, acting as principals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales of shares of our common stock, if any, under this prospectus supplement and the accompanying prospectus may be made (1)&nbsp;in &#147;at the
market&#148; offerings (as defined in Rule 415 under the Securities Act) by means of ordinary brokers&#146; transactions at market prices prevailing at the time of sale, including sales made on the NYSE, sales made to or through market makers and
sales made through other securities exchange or electronic communications networks and (2)&nbsp;in such privately negotiated transactions, which may include block trades, as we and any Manager may agree. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the Managers is required to sell any specific number or dollar amount of shares of our common stock but each has agreed to use its commercially
reasonable efforts to sell, on the terms and subject to the conditions of the Distribution Agreement, shares of our common stock on terms agreed upon by us and such Manager from time to time. The shares of our common stock offered and sold through
the Managers, as our agents, pursuant to the Distribution Agreement will be offered and sold through only one Manager on any given day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In no event will
the aggregate gross sales price of shares of our common stock sold by us to or through the Managers, acting as our agents or as principals, exceed $200,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have agreed that we will indemnify the Managers against certain liabilities, including liabilities under the Securities Act, or contribute to payments that
the Managers may be required to make in respect of those liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that the expenses payable by us in connection with the offering and
sale of shares of our common stock pursuant to the Distribution Agreement, other than discounts and commissions but including expenses paid prior to the date of this prospectus supplement, will be approximately $500,000. The remaining sales proceeds
from the sale of any shares of our common stock, after deducing any transaction fees, transfer taxes or similar fees, taxes or charges imposed by any governmental or self-regulatory organization in connection with such sales, shall constitute the
net proceeds from the sale of our common stock offered by this prospectus supplement and the accompanying prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offering of shares of our
common stock pursuant to the Distribution Agreement will terminate upon the earlier of (1)&nbsp;the sale of shares of our common stock having an aggregate gross sales price of $200,000,000 pursuant to the Distribution Agreement (including shares
sold prior to the date of this prospectus supplement) and (2)&nbsp;the termination of the Distribution Agreement by us or by the parties thereto by mutual agreement. Any Manager may also terminate the Distribution Agreement but only with respect to
itself. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is an &#147;actively-traded security&#148; excepted from the requirements of Rule 101 of Regulation M under the Exchange Act by
Rule 101(c)(1) of Regulation M. If a Manager has, or if we have, reason to believe that the exemptive provisions set forth in Rule 101(c)(1) of Regulation M under the Exchange Act are not satisfied, such party will promptly notify the other parties
to the Distribution Agreement and sales of our common stock under the Distribution Agreement will be suspended until that or other exemptive provisions have been satisfied in the judgment of us and the Managers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon its acceptance of instructions from us, each Manager has agreed to use its commercially reasonable efforts to sell shares of our common stock, as our
agent, on the terms and subject to the conditions set forth in the Distribution Agreement. We will instruct each Manager as to the amount of common stock to be sold by it as our agent. We may instruct a Manager not to sell our common stock as our
agent if the sales cannot be effected at or above a price designated by us. We or any Manager may at any time immediately suspend the offering of shares of our common stock through such Manager, as our agent, upon notice to the other party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The applicable Manager will provide written confirmation prior to the opening of trading on the NYSE on the
immediately following day on which shares of our common stock are sold through such Manager, as our agent, under the Distribution Agreement. Each confirmation will include the number of shares of our common stock sold on that day, the gross sales
price per share, the aggregate gross sales price of the shares of our common stock sold, the net proceeds and the compensation payable by us to such Manager in connection with such sales of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will pay the applicable Manager a commission at a rate equal to (except as provided below) up to 3.0% of the gross sales price per share of our common
stock sold through such Manager, as our agent, under the Distribution Agreement. We may also agree with any Manager, acting as our agent, to sell shares of our common stock other than through ordinary brokers&#146; transactions using sales efforts
and methods that may constitute &#147;distributions&#148; within the meaning of Rule 100 of Regulation M under the Exchange Act and for which we may agree to pay such Manager a commission that may exceed 3.0% of the gross sales price per share of
our common stock sold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the Distribution Agreement, we may also sell shares of our common stock to one or more of the Managers, as
principal(s), at a price per share to be agreed upon at the time of sale. If we sell shares to one or more of the Managers as principal(s), we will enter into a separate terms agreement with such Manager or Managers, as the case may be, and we will
describe the terms of the offering of those shares in a separate prospectus supplement. In any such sale to a Manager as principal, we may agree to pay the applicable Manager a commission or discount that may exceed 3.0% of the gross sales price per
share of common stock sold to such Manager, as principal. None of the Managers has any obligation to purchase shares of common stock from us and may elect whether or not to do so in its sole and absolute discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Managers and their affiliates are full service financial institutions engaged in various activities, which may include sales and trading, commercial and
investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and other financial and <FONT STYLE="white-space:nowrap">non-financial</FONT> activities and services. Certain of the
Managers and their affiliates have provided, and may in the future provide, a variety of these services to us and to persons and entities with relationships with us, for which they received or will receive customary fees and expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the ordinary course of their various business activities, the Managers and their affiliates, officers, directors and employees may purchase, sell or hold a
broad array of investments and actively trade securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments for their own account and for the accounts of their customers, and such investment and
trading activities may involve or relate to our assets, securities and/or instruments (directly, as collateral securing other obligations or otherwise) and/or persons and entities with relationships with us. The Managers and their affiliates may
also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such assets, securities or instruments and may at any time hold, or recommend to clients that
they should acquire, long and/or short positions in such assets, securities and instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than in the United States, no action has been taken by
us or the Managers that would permit a public offering of the shares of common stock offered by this prospectus supplement and the accompanying prospectus in any jurisdiction where action for that purpose is required. The shares offered by this
prospectus supplement may not be offered or sold, directly or indirectly, nor may this prospectus supplement or any other offering material or advertisements in connection with the offer and sale of any such shares be distributed or published in any
jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus supplement comes are advised to inform themselves about and to
observe any restrictions relating to the offering and the distribution of this prospectus supplement. This prospectus supplement does not constitute an offer to sell or a solicitation of an offer to buy any shares of common stock offered by this
prospectus supplement in any jurisdiction in which such an offer or a solicitation is unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should be aware that the laws and practices of
certain countries require investors to pay stamp taxes and other charges in connection with purchases of securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_10"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following discussion is a summary of the material U.S. federal income tax consequences to <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders (as defined below) of the purchase, ownership and disposition of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The
effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of
1986, as amended (the &#147;Code&#148;), Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#147;IRS&#148;), in each case in effect as
of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that
discussed below regarding the tax consequences of the purchase, ownership and disposition of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discussion is limited to <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders that hold our common stock as a &#147;capital asset&#148; within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). This discussion does not address all U.S.
federal income tax consequences relevant to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s particular circumstances, including the impact of the Medicare contribution tax on net investment income and any alternative minimum tax. In
addition, it does not address consequences relevant to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders subject to special rules, including, without limitation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. expatriates and former citizens or long-term residents of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons holding our common stock as part of a hedge, straddle or other risk reduction strategy or as part of a
conversion transaction or other integrated investment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">banks, insurance companies and other financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers, dealers or traders in securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies&#148; and corporations
that accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and
investors therein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations or governmental organizations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons deemed to sell our common stock under the constructive sale provisions of the Code;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise
as compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plans; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;qualified foreign pension funds&#148; as defined in Section&nbsp;897(l)(2) of the Code and entities all of
the interests of which are held by qualified foreign pension funds. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an entity or arrangement treated as a partnership for U.S.
federal income tax purposes holds our common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly,
partnerships holding our common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS DISCUSSION IS NOT TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS </B></P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE
LAWS OF ANY STATE, LOCAL OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Definition of a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a <FONT STYLE="white-space:nowrap">&#147;Non-U.S.</FONT> Holder&#148; is any beneficial owner of our common stock that is
neither a &#147;U.S. person&#148; nor an entity treated as a partnership for U.S. federal income tax purposes. A U.S. person is any person that, for U.S. federal income tax purposes, is or is treated as any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a corporation created or organized under the laws of the United States, any state thereof, or the District of
Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a trust that (1)&nbsp;is subject to the primary supervision of a U.S. court and all substantial decisions of
which are subject to the control of one or more &#147;United States persons&#148; (within the meaning of Section&nbsp;7701(a)(30) of the Code), or (2)&nbsp;has a valid election in effect to be treated as a United States person for U.S. federal
income tax purposes. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described in the section titled &#147;Dividend Policy,&#148; we currently do not plan to pay any cash dividends to holders of our common stock in the
foreseeable future. However, if we do make distributions of cash or property on our common stock, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and
profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital and first be applied against and reduce a
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s adjusted tax basis in its common stock, but not below zero. Any excess will be treated as capital gain and will be treated as described below under &#147;&#151; Sale or Other Taxable
Disposition.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion below regarding effectively connected income, dividends paid to a
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income tax treaty, provided the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder furnishes a valid IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or other applicable
documentation) certifying qualification for the lower treaty rate). A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund
of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders should consult their tax advisors regarding their entitlement to benefits under any applicable
income tax treaties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If dividends paid to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder are effectively connected with the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder maintains a permanent
establishment in the United States to which such dividends are attributable), the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder will be exempt from the U.S. federal withholding tax described above. To claim the exemption, the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder must furnish to the applicable withholding agent a valid IRS Form <FONT STYLE="white-space:nowrap">W-8ECI,</FONT> certifying that the dividends are effectively connected with the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s conduct of a trade or business within the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any such effectively connected
dividends will be subject to U.S. federal income tax on a net income basis at the regular rates applicable to U.S. persons. A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that is a corporation also may be subject to a branch profits tax
at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as adjusted for certain items. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders should consult their tax advisors
regarding any applicable tax treaties that may provide for different rules. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sale or Other Taxable Disposition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under &#147;Information Reporting and Backup Withholding&#148; and &#147;Additional Withholding Tax on Payments Made to Foreign
Accounts&#148;, a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder will not be subject to U.S. federal income tax on any gain realized upon the sale or other taxable disposition of our common stock unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s
conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder maintains a permanent establishment in the United States to which such gain is
attributable); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is a nonresident alien individual present in the
United States for 183 days or more during the taxable year of the disposition and certain other requirements are met; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">our common stock constitutes a U.S. real property interest (&#147;USRPI&#148;) by reason of our status as a
U.S. real property holding corporation (&#147;USRPHC&#148;) for U.S. federal income tax purposes. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gain described in the first bullet
point above generally will be subject to U.S. federal income tax on a net income basis at the regular rates applicable to U.S. persons. A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that is a corporation also may be subject to a branch
profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder described in the second bullet point above will be subject to U.S. federal income tax at a rate of
30% (or such lower rate specified by an applicable income tax treaty) on gain realized upon the sale or other taxable disposition of our common stock, which may be offset by certain U.S. source capital losses of the
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder (even though the individual is not considered a resident of the United States), provided the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder has timely filed U.S. federal income tax
returns with respect to such losses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to the third bullet point above, we believe we currently are not, and do not anticipate becoming, a
USRPHC. Because the determination of whether we are a USRPHC depends, however, on the fair market value of our USRPIs relative to the fair market value of our <FONT STYLE="white-space:nowrap">non-U.S.</FONT> real property interests and our other
business assets, there can be no assurance we currently are not a USRPHC or will not become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition of our common stock by a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder will not be subject to U.S. federal income tax if our common stock is &#147;regularly traded,&#148; as defined by applicable Treasury Regulations, on an established securities market and such <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder owned, actually and constructively, 5% or less of our common stock throughout the shorter of the <FONT STYLE="white-space:nowrap">five-year</FONT> period ending on the date of the sale or other
taxable disposition or the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s holding period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders should consult their tax advisors regarding any applicable income tax treaties that may provide for
different rules. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payments of dividends on our common stock will not be subject to backup withholding, provided the applicable withholding agent does not have actual knowledge
or reason to know the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is a United States person and the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder certifies its <FONT STYLE="white-space:nowrap">non-U.S.</FONT> status, such as by
furnishing a valid IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or <FONT STYLE="white-space:nowrap">W-8ECI,</FONT> or otherwise establishes an
exemption. However, information returns are required to be filed with the IRS in connection with any distributions on our common stock paid to the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder, regardless of whether such distributions
constitute dividends or whether any tax was actually withheld. In addition, proceeds of the sale or other taxable disposition of our common stock within the United States or conducted through certain U.S.-related brokers generally will not be
subject to backup withholding or information reporting if the applicable withholding agent receives the certification described above or the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder otherwise establishes an exemption. Proceeds of a
disposition of our common stock conducted through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> broker that does not have certain enumerated relationships with the United States
generally will not be subject to backup withholding or information reporting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of information returns that are filed with the IRS may also be made available under the provisions of
an applicable treaty or agreement to the tax authorities of the country in which the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder resides or is established. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Withholding Tax on Payments Made to Foreign Accounts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Withholding taxes may be imposed under Sections 1471 to 1474 of the Code (such Sections commonly referred to as the Foreign Account Tax Compliance Act
(&#147;FATCA&#148;) on certain types of payments made to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> financial institutions and certain other <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entities. Specifically, a 30% withholding tax may be
imposed on dividends on, or, subject to the proposed Treasury Regulations discussed below, gross proceeds from the sale or other disposition of, our common stock paid to a &#147;foreign financial institution&#148; or a
<FONT STYLE="white-space:nowrap">&#147;non-financial</FONT> foreign entity&#148; (each as defined in the Code), unless (1)&nbsp;the foreign financial institution undertakes certain diligence and reporting obligations, (2)&nbsp;the <FONT
STYLE="white-space:nowrap">non-financial</FONT> foreign entity either certifies it does not have any &#147;substantial United States owners&#148; (as defined in the Code) or furnishes identifying information regarding each substantial United States
owner, or (3)&nbsp;the foreign financial institution or <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial institution and is subject to the
diligence and reporting requirements in (1)&nbsp;above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by certain &#147;specified United States
persons&#148; or &#147;United States owned foreign entities&#148; (each as defined in the Code), annually report certain information about such accounts, and withhold 30% on certain payments to <FONT STYLE="white-space:nowrap">non-compliant</FONT>
foreign financial institutions and certain other account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the applicable Treasury Regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends on our common stock.
While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition of our common stock beginning on January&nbsp;1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments of
gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prospective
investors should consult their tax advisors regarding the potential application of withholding under FATCA to their investment in our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain legal matters relating to this offering will be passed upon for us by Latham&nbsp;&amp; Watkins LLP. Davis Polk&nbsp;&amp; Wardwell LLP is acting as
counsel to the Managers in connection with certain legal matters relating to the shares of common stock being offered hereby. Certain matters of North Carolina law, including the validity of our common stock, will be passed upon for us by Smith,
Anderson, Blount, Dorsett, Mitchell&nbsp;&amp; Jernigan, LLP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial statements and management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included in
Management&#146;s Report on Internal Control over Financial Reporting) incorporated in this Prospectus by reference to the Annual Report on Form 10-K for the year ended June 30, 2024 have been so incorporated in reliance on the report of
PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_13"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus are part of the registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> we filed
with the SEC under the Securities Act and do not contain all the information set forth in the registration statement. Whenever a reference is made in this prospectus supplement or the accompanying prospectus to any of our contracts, agreements or
other documents, the reference may not be complete and you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents incorporated by reference in this prospectus supplement and the
accompanying prospectus for a copy of such contract, agreement or other document. We file annual, quarterly and special reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy statements
and other information about issuers, such as us, who file electronically with the SEC. The address of that website is www.sec.gov. Our public filings are also available to the public on our website at www.wolfspeed.com. The information contained on
our website, however, is not, and should not be deemed to be, a part of this prospectus supplement, the accompanying prospectus or any other report or filing filed with the SEC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc840767_14"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; the information we file with them which means that we can disclose important information to you by
referring you to those documents instead of having to repeat the information in this prospectus supplement and accompanying prospectus. The information incorporated by reference is considered to be part of this prospectus supplement and accompanying
prospectus, and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000062/wolf-20240630.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended June&nbsp;30, 2024, filed with the SEC on August&nbsp;22, 2024. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The information specifically incorporated by reference into our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> from our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000078/wolf-20241017.htm">Schedule 14A</A>, filed with the SEC on
October&nbsp;17, 2024, as supplemented by the <A HREF="http://www.sec.gov/Archives/edgar/data/895419/000089541924000103/defa14a2024-proxysupplement.htm">Proxy Supplement on Schedule 14A</A>, filed with the SEC on November 20, 2024.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000895419/000089541924000093/wolf-20240929.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the fiscal quarter ended September&nbsp;29, 2024 filed with the SEC on November<U></U>&nbsp;7, 2024. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (other than information furnished rather
than filed) filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000119312524237183/d891469d8k.htm">October<U></U>&nbsp;
15, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000074/wolfspeed-20241016.htm">October<U></U>&nbsp;
16, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000119312524238116/d878067d8k.htm">October<U></U>&nbsp;
16, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000084/wolfspeed-20241022.htm">October<U></U>&nbsp;
22, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000087/wolf-20241106.htm">November<U></U>&nbsp;
6, 2024</A> (solely with respect to Item 2.05), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000119312524260426/d915019d8k.htm">November<U></U>&nbsp;
18, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000107/wolfspeed-20241119.htm">November<U></U>&nbsp;
21, 2024</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000132/wolfspeed-20241205.htm">December<U></U>&nbsp;6, 2024</A>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our common stock contained in our Registration Statement on Form <FONT
STYLE="white-space:nowrap">8-A</FONT> filed on <A HREF="http://www.sec.gov/Archives/edgar/data/895419/000089541921000118/form8a093021.htm">September 30, 2021</A>, as updated by the description of our registered securities contained in <A HREF="http://www.sec.gov/Archives/edgar/data/895419/000089541923000135/exhibit43-descriptionofreg.htm">Exhibit
 4.3</A> to our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000895419/000089541923000135/wolf-20230924.htm">Form <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended
September&nbsp;24, 2023, filed with the SEC on November&nbsp;2, 2023, and any amendment or report filed for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All reports and other documents we subsequently file pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of this
offering but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus supplement and deemed to be part of this prospectus supplement from the date of the filing of such
reports and documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a free copy of any of the documents incorporated by reference in this prospectus supplement by writing or
telephoning us at the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Wolfspeed, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4600
Silicon Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Durham, North Carolina 27703 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(919) <FONT STYLE="white-space:nowrap">407-7895</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus supplement or
accompanying prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g737660g24g51.jpg" ALT="LOGO" STYLE="width:1.40997in;height:0.45485in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Wolfspeed, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Preferred
Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt Securities </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Purchase
Contracts </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may offer and
sell the securities identified above from time to time in one or more offerings. This prospectus provides you with a general description of the securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each time we offer and sell securities, we will provide a supplement to this prospectus that contains specific information about the offering and the amounts,
prices, and terms of the securities. The supplement may also add, update, or change information contained in this prospectus with respect to that offering. You should carefully read this prospectus and the applicable prospectus supplement before you
invest in any of our securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may offer and sell the securities described in this prospectus and any prospectus supplement to or through one or
more underwriters, dealers, and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers, or agents are involved in the sale of any of the securities, their names and any applicable purchase price,
fee, commission, or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. See the sections of this prospectus entitled &#147;About this
Prospectus&#148; and &#147;Plan of Distribution&#148; for more information. No securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and terms of the offering of such securities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>INVESTING IN OUR SECURITIES INVOLVES RISKS. SEE THE &#147;<A HREF="#toc737660_5">RISK&nbsp;FACTORS</A>&#148; ON PAGE&nbsp;6 OF THIS PROSPECTUS AND ANY
SIMILAR SECTION CONTAINED IN THE APPLICABLE PROSPECTUS SUPPLEMENT AND IN THE DOCUMENTS INCORPORATED BY REFERENCE IN THIS PROSPECTUS OR ANY PROSPECTUS SUPPLEMENT CONCERNING FACTORS YOU SHOULD CONSIDER BEFORE INVESTING IN OUR SECURITIES. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the New York Stock Exchange under the symbol &#147;WOLF.&#148; On December&nbsp;6, 2024, the last reported sale price of our
common stock on the New York Stock Exchange was $9.45 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission
has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is December&nbsp;9, 2024. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_2">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_3">WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY
REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_4">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_5">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_7">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_8">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_9">DESCRIPTION OF OTHER SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_10">GLOBAL SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_11">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_12">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc737660_13">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission (the &#147;SEC&#148;) as a &#147;well-known
seasoned issuer&#148; as defined in Rule 405 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), using a &#147;shelf&#148; registration process. By using a shelf registration statement, we may sell securities from time to
time and in one or more offerings as described in this prospectus. Each time that we offer and sell securities, we will provide a prospectus supplement to this prospectus that contains specific information about the securities being offered and sold
and the specific terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement or free writing prospectus may
also add, update, or change information contained in this prospectus with respect to that offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or free writing prospectus, you
should rely on the prospectus supplement or free writing prospectus, as applicable. Before purchasing any securities, you should carefully read both this prospectus and the applicable prospectus supplement (and any applicable free writing
prospectuses), together with the additional information described under the heading &#147;Where You Can Find More Information; Incorporation by Reference.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any applicable
prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give
you. We will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus and the applicable prospectus supplement to this prospectus is
accurate only as of the date on its respective cover, that the information appearing in any applicable free writing prospectus is accurate only as of the date of that free writing prospectus, and that any information incorporated by reference is
accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations, and prospects may have changed since those dates. This prospectus incorporates by
reference, and any prospectus supplement or free writing prospectus may contain and incorporate by reference, market data and industry statistics and forecasts that are based on independent industry publications and other publicly available
information. Although we believe these sources are reliable, we do not guarantee the accuracy or completeness of this information and we have not independently verified this information. In addition, the market and industry data and forecasts that
may be included or incorporated by reference in this prospectus, any prospectus supplement or any applicable free writing prospectus may involve estimates, assumptions, and other risks and uncertainties and are subject to change based on various
factors, including those discussed under the heading &#147;Risk Factors&#148; contained in this prospectus, the applicable prospectus supplement, and any applicable free writing prospectus, and under similar headings in other documents that are
incorporated by reference into this prospectus. Accordingly, investors should not place undue reliance on this information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When we refer to
&#147;Wolfspeed,&#148; &#147;we,&#148; &#147;our,&#148; &#147;us&#148; and the &#147;Company&#148; in this prospectus, we mean Wolfspeed, Inc. and its consolidated subsidiaries, unless otherwise specified. When we refer to &#147;you,&#148; we mean
the potential holders of the applicable series of securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our logo and other registered or common law trademarks, tradenames, or service marks
appearing or incorporated by reference in this prospectus or any prospectus supplement or applicable free writing prospectus are our property. Solely for convenience, our trademarks, tradenames, and service marks referred to in this prospectus or
any document incorporated by reference herein may be without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, TM, and SM symbols, as applicable, but this is not intended to indicate, in any way, that we will not assert, to the fullest
extent under applicable law, our rights to these trademarks, tradenames, and service marks. This prospectus, any applicable prospectus supplement or applicable free writing prospectus, and the documents incorporated therein by reference may contain
additional trademarks, tradenames, and service marks of other companies that are the property of their respective owners. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_2"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information set forth in this prospectus and any applicable prospectus supplement and the information they incorporate by reference may contain various
&#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act. All information relative to future markets for our products and trends in and anticipated levels of
revenue, gross margins, and expenses, as well as other statements containing words such as &#147;believe,&#148; &#147;project,&#148; &#147;may,&#148; &#147;will,&#148; &#147;anticipate,&#148; &#147;target,&#148; &#147;plan,&#148;
&#147;estimate,&#148; &#147;expect,&#148; and &#147;intend&#148; and other similar expressions constitute forward-looking statements. These forward-looking statements are subject to business, economic, and other risks and uncertainties, both known
and unknown, and actual results may differ materially from those contained in the forward-looking statements. Examples of risks and uncertainties that could cause actual results to differ materially from historical performance and any
forward-looking statements include, but are not limited to, the risks described in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> and any subsequent Quarterly Reports on Form
<FONT STYLE="white-space:nowrap">10-Q</FONT> or Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> we file after the date of this prospectus. Given these risks, uncertainties, and other factors, you should not place undue reliance
on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date such forward-looking statements are made. You should read carefully this prospectus, any applicable prospectus
supplement, and any related free writing prospectuses that we have authorized for use in connection with a specific offering, together with the information incorporated herein or therein by reference as described under the heading &#147;Where You
Can Find More Information; Incorporation by Reference,&#148; completely and with the understanding that our actual future results may be materially different from what we expect. We hereby qualify all of our forward-looking statements by these
cautionary statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements,
even if new information becomes available in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_3"></A>WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Available Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file reports, proxy
statements, and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements, and other information about issuers, such as us, who file electronically with the SEC. The address of that website
is www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our website address is www.wolfspeed.com<I>. </I>The information on our website, however, is not, and should not be deemed to be, a part
of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and any prospectus supplement are part of a registration statement that we filed with the SEC and do not contain all
of the information in the registration statement. The full registration statement may be obtained from the SEC or us, as provided below. Forms of the indenture and other documents establishing the terms of the offered securities are or may be filed
as exhibits to the registration statement or documents incorporated by reference in the registration statement. Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all
respects by reference to the document to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. You may inspect a copy of the registration statement through the SEC&#146;s website, as
provided above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Incorporation by Reference </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
SEC&#146;s rules allow us to &#147;incorporate by reference&#148; information into this prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information
incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information. Any statement contained in this prospectus or a previously filed
document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or a subsequently filed document incorporated by reference modifies or
replaces that statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that have
previously been filed with the SEC: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000062/wolf-20240630.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended June&nbsp;30, 2024, filed with the SEC on August&nbsp;22, 2024. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The information specifically incorporated by reference into our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> from our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000895419/000089541924000078/wolf-20241017.htm">Schedule 14A</A>, filed with the SEC
on October&nbsp;17, 2024, as supplemented by the <A HREF="http://www.sec.gov/Archives/edgar/data/895419/000089541924000103/defa14a2024-proxysupplement.htm">Proxy Supplement on Schedule 14A</A>, filed with the SEC on November 20, 2024.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000093/wolf-20240929.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the fiscal quarter ended September&nbsp;29, 2024 filed with the SEC on November<U></U>&nbsp;7, 2024. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (other than information furnished rather
than filed) filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000119312524237183/d891469d8k.htm">October<U></U>&nbsp;
15, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000074/wolfspeed-20241016.htm">October<U></U>&nbsp;
16, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000119312524238116/d878067d8k.htm">October<U></U>&nbsp;
16, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000084/wolfspeed-20241022.htm">October<U></U>&nbsp;
22, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000087/wolf-20241106.htm">November<U></U>&nbsp;
6, 2024</A> (solely with respect to Item 2.05), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000119312524260426/d915019d8k.htm">November<U></U>&nbsp;
18, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000107/wolfspeed-20241119.htm">November<U></U>&nbsp;
21, 2024</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541924000132/wolfspeed-20241205.htm">December<U></U>&nbsp;6, 2024</A>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our common stock contained in our Registration Statement on Form <FONT
STYLE="white-space:nowrap">8-A</FONT> filed on <A HREF="http://www.sec.gov/Archives/edgar/data/895419/000089541921000118/form8a093021.htm">September 30, 2021</A>, as updated by the description of our registered securities contained in <A HREF="http://www.sec.gov/Archives/edgar/data/895419/000089541923000135/exhibit43-descriptionofreg.htm">Exhibit
 4.3</A> to our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/895419/000089541923000135/wolf-20230924.htm">Form <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended
September&nbsp;24, 2023, filed with the SEC on November&nbsp;2, 2023, and any amendment or report filed for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All reports and other documents we subsequently file pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended,
which we refer to as the &#147;Exchange Act&#148; in this prospectus, prior </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to the termination of this offering but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part
of this prospectus from the date of the filing of such reports and documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a free copy of any of the documents incorporated by
reference in this prospectus by writing or telephoning us at the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Wolfspeed, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4600
Silicon Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Durham, North Carolina 27703 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(919) <FONT STYLE="white-space:nowrap">407-7895</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus or any
accompanying prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_4"></A>THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide materials and devices for power applications. Our product families
include power devices and silicon carbide and gallium nitride materials. Our products are targeted for various applications such as electric vehicles, fast charging and renewable energy and storage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our materials products and power devices are used in electric vehicles, motor drives, power supplies, solar and transportation applications. Our materials
products are also used in military communications, radar, satellite and telecommunication applications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During and prior to fiscal 2024, we designed,
manufactured and sold radio-frequency (&#147;RF&#148;) devices. We completed the sale of certain assets comprising our former RF product line (the &#147;RF Business Divestiture&#148;) in the second quarter of fiscal 2024. The RF Business Divestiture
represented a strategic shift that had a major effect on our operations and financial results. As a result, we have classified the results and cash flows of the RF product line as discontinued operations in our consolidated statements of operations
and consolidated statements of cash flows for all periods presented. Additionally, the related assets and liabilities associated with the transaction are classified as held for sale in the consolidated balance sheet as of June&nbsp;25, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The majority of our products are manufactured at our production facilities located in North Carolina, New York and Arkansas. We also use contract
manufacturers for certain products and aspects of product fabrication, assembly and packaging. We maintain captive lines at some of our contract manufacturers. We are constructing a new materials manufacturing facility in North Carolina. We operate
research and development facilities in North Carolina, Arkansas and New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wolfspeed, Inc. is a North Carolina corporation established in 1987, and
our headquarters are in Durham, North Carolina. Our principal executive offices are located at 4600 Silicon Drive, Durham, North Carolina 27703. Our telephone number is (919) <FONT STYLE="white-space:nowrap">407-5300.</FONT> Our website address is
www.wolfspeed.com. The information on, or otherwise accessible through, our website does not constitute a part of this prospectus or any accompanying prospectus supplement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;15, 2024,
Wolfspeed, Inc. and certain current and former executive officers were named as defendants in a securities class action lawsuit captioned Gary Zagami v. Wolfspeed, Inc., et al., Case No. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">6:24-cv-01395,</FONT></FONT> which was filed in the United States District Court for the Northern District of New York. The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934,
and Rule <FONT STYLE="white-space:nowrap">10b-5</FONT> promulgated thereunder. The complaint seeks unspecified compensatory damages and other relief. It is possible that additional lawsuits will be filed, or allegations made, by shareholders
regarding these same or other matters and also naming as defendants the Company and its officers and directors. We deny the allegations of wrongdoing and intend to vigorously defend against the claims in the above-referenced action. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investment in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. Before deciding whether to invest in
our securities, you should carefully consider the risk factors incorporated by reference to our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and any subsequent Quarterly Reports on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> or Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the
Exchange Act, and the risk factors and other information contained in the applicable prospectus supplement and any applicable free writing prospectus. The occurrence of any of these risks might cause you to lose all or part of your investment in the
offered securities. There may be other unknown or unpredictable economic, business, competitive, regulatory, or other factors that could have material adverse effects on our future results. Past financial performance may not be a reliable indicator
of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business, financial condition, results of operations, or cash flow could be seriously
harmed. This could cause the trading price of our securities to decline, resulting in a loss of all or part of your investment. Please also carefully read the section entitled &#147;Forward-Looking Information&#148; included in our most recent
Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and any subsequent Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Current Reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds from the sale of the securities as set forth in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_7"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This section describes the general terms and provisions of our capital stock. This description is only a summary and is qualified in its entirety by reference
to our amended and restated articles of incorporation (the &#147;Articles of Incorporation&#148;) and our amended and restated bylaws (the &#147;Bylaws&#148;) and applicable provisions of the North Carolina Business Corporation Act (the
&#147;NCBCA&#148;). Our Articles of Incorporation and our Bylaws have been filed as exhibits to our periodic reports filed with the SEC, which are incorporated by reference in this prospectus. See &#147;Where You Can Find More Information;
Incorporation by Reference.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized Capital Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Articles of Incorporation authorize us to issue 400,000,000 shares of common stock, par value $0.00125 per share, and 3,000,000 shares of preferred stock,
par value $0.01 per share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to
the rights specifically granted to holders of any outstanding shares of our preferred stock, our common shareholders are entitled to one vote for each share held and are entitled to vote together as a class on all matters submitted to a vote of our
shareholders. When a quorum is present and except as otherwise provided by law, our Articles of Incorporation or our Bylaws, action on a matter by a voting group is approved if the votes cast within the voting group favoring the action exceed the
votes cast against the action. An election of directors by our shareholders is determined by a plurality of the votes cast by the shareholders entitled to vote on the election. Shareholders are entitled to any dividends that may be declared by our
board of directors. Our common shareholders do not have cumulative voting rights. Upon our dissolution, liquidation, or winding up, holders of our common stock are entitled to share ratably in our net assets after payment or provision for all
liabilities and preferential liquidation rights of our preferred stock then outstanding. Our common shareholders have no preemptive rights to purchase shares of our common stock. The issued and outstanding shares of our common stock are not subject
to any redemption or sinking fund provisions and are not convertible into any other shares of our capital stock. The rights, preferences, and privileges of holders of our common stock are subject to those of the holders of any shares of our
preferred stock that we may issue in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the provisions of our Articles of Incorporation, our board of directors has the authority, without further action by our shareholders, to issue up
to 3,000,000 shares of preferred stock in one or more series and to determine the preferences, limitations, and relative rights of the preferred stock before issuance of any shares of that class and of any series of preferred stock before issuance
of shares of that series. These preferences, limitations, and relative rights could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms, and the number of shares constituting,
or the designation of, such series, any or all of which may be greater than the rights of our common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders
will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring, or preventing a change in control of our company or other corporation action. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Equiniti Trust Company, LLC
is the transfer agent and registrar for our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock Exchange Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is traded on the New York Stock Exchange and is quoted under the symbol &#147;WOLF.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Provisions of our Articles of Incorporation and Bylaws; Director Indemnification; Exclusive Forum
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Authorized but Unissued Stock</I>. Our Articles of Incorporation authorize the issuance of a significant number of shares of common stock and
preferred stock. A large quantity of authorized but unissued shares may deter potential takeover attempts because of the ability of our board of directors to authorize the issuance of some or all of these shares to a friendly party, or to the
public, which would make it more difficult for a potential acquirer to obtain control of our company. This possibility may encourage persons seeking to acquire control of our company to negotiate first with our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our authorized but unissued shares of preferred stock could also have other anti-takeover effects. Under certain circumstances, any or all of the preferred
stock could be used as a method of discouraging, delaying, or preventing a change in control or management of our company. For example, our board of directors could designate and issue a series of preferred stock in an amount that sufficiently
increases the number of outstanding shares to overcome a vote by the holders of common stock, or with rights and preferences that include special voting rights to veto a change in control. The preferred stock could also be used in connection with
the issuance of a shareholder rights plan, sometimes referred to as a &#147;poison pill.&#148; Our board of directors is able to implement a shareholder rights plan without further action by our shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Use of our preferred stock in the foregoing manner could delay or frustrate a merger, tender offer, or proxy contest, the removal of incumbent directors or
the assumption of control by shareholders, even if these actions would be beneficial to our shareholders. In addition, the existence of authorized but unissued shares of preferred stock could discourage bids for our company even if such bid
represents a premium over our then-existing trading price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Advance Notice of Proposals and Nominations</I>. Our Bylaws provide that shareholders must
provide timely written notice to bring business before an annual meeting of shareholders or to nominate candidates for election as directors at an annual meeting of shareholders. Notice for an annual meeting is timely if it is received at our
principal office not less than 90 days and no more than 120 days prior to the first anniversary of the preceding year&#146;s annual meeting. However, if the date of the annual meeting is advanced by more than 30 days or delayed by more than 60 days
from this anniversary date, such notice by the shareholder must be delivered not earlier than the 120th day prior to the annual meeting and no later than the close of business on the later of the 90th day prior to such annual meeting or the tenth
day following the day on which public announcement of the date of such annual meeting was first made. Our Bylaws also specify the form and content of a shareholder&#146;s notice. These provisions may prevent shareholders from bringing matters before
an annual meeting of shareholders or from nominating candidates for election as directors at an annual meeting of shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limits on Special
Meetings</I>. A special meeting of the shareholders may only be called by our board of directors or by the chair of our board of directors. Our Bylaws do not grant shareholders the authority to request a special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Indemnification of Directors, Officers, and Employees</I>. Our Bylaws provide that we shall indemnify, to the fullest extent permitted by law, any person
who is made, or is threatened to be made, a party to any threatened, pending or completed civil, criminal, administrative, investigative or arbitrative action, suit, or proceeding and any appeal therein (and any inquiry or investigation that could
lead to such action, suit, or proceeding), whether or not brought by or on behalf of Wolfspeed, seeking to hold such person liable by reason of the fact that such person is or was acting in such capacity as a director or officer of Wolfspeed, or at
the request of Wolfspeed is or was serving as a director or officer for any other foreign or domestic corporation, partnership, limited liability company, joint venture, trust employee benefit or other enterprise, or as a trustee or administrator
under any employee benefit plan of Wolfspeed or a wholly-owned subsidiary of Wolfspeed, against (i)&nbsp;reasonable expenses, including without limitation all attorneys&#146; fees actually and necessarily incurred by such person in connection with
any such action, suit, or proceeding; (ii)&nbsp;all reasonable payments made by such person in satisfaction of any judgment, money decree, fine (including an excise tax assessed with respect to an employee benefit plan), penalty or settlement for
which such person may have become liable in such action, suit, or proceeding; and (iii)&nbsp;all reasonable expenses incurred in enforcing the indemnification rights provided in our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Bylaws. Pursuant to our Bylaws, this indemnification may, at our board of directors&#146; discretion, also include advancement of expenses related to such action, suit, or proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have also entered into an indemnification agreement with each of our directors and executive officers. The indemnification agreement requires Wolfspeed to
indemnify the indemnitee to the fullest extent permitted by the laws of the State of North Carolina currently in effect or as such laws may be amended to increase the scope of permitted indemnification. The indemnification agreement further requires
Wolfspeed to advance expenses incurred in connection with an action, demand, suit, or proceeding and includes an undertaking by the indemnitee to reimburse Wolfspeed for any amounts advanced if it is ultimately determined that indemnification is not
proper. The rights provided in the indemnification agreement are in addition to rights provided in our Bylaws and the NCBCA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exclusive Forum</I>. Our
Bylaws provide that, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for all litigation relating to our internal affairs, including without limitation (i)&nbsp;any derivative action or proceeding
brought on behalf of Wolfspeed, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of Wolfspeed to Wolfspeed or our shareholders, (iii)&nbsp;any action asserting a claim arising
pursuant to any provision of the NCBCA, our Articles of Incorporation, or our Bylaws, (iv)&nbsp;any action to interpret, apply, enforce or determine the validity of our Articles of Incorporation or Bylaws, or (v)&nbsp;any action asserting a claim
governed by the internal affairs doctrine, shall be the state courts of North Carolina or, if such courts lack jurisdiction, a federal court located within the State of North Carolina, in all cases subject to the court&#146;s having personal
jurisdiction over the indispensable parties named as defendants. Any such action filed in a North Carolina state court shall be designated by the party filing the action as a mandatory complex business case. In any such action where the NCBCA
specifies the division or county wherein the action must be brought, the action shall be brought in such division or county. Our Bylaws also provide that, notwithstanding the foregoing, (x)&nbsp;the provisions described above will not apply to suits
brought to enforce any liability or duty created by the Exchange Act, or any other claim for which the federal courts have exclusive jurisdiction, and (y)&nbsp;unless we consent in writing to the selection of an alternative forum, the federal
district courts shall, to the fullest extent permitted by law, be the exclusive forum for the resolution of any complaint asserting a cause of action against Wolfspeed or any director, officer, employee, or agent of Wolfspeed and arising under the
Securities Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Anti-Takeover Effects of North Carolina Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The North Carolina Shareholder Protection Act (the &#147;Act&#148;), generally requires the affirmative vote of 95% of a corporation&#146;s voting shares to
approve a &#147;business combination&#148; with any entity that is the beneficial owner, directly or indirectly, of more than 20% of the voting shares of the corporation (or has ever owned, directly or indirectly, more than 20% and is still an
&#147;affiliate&#148; of the corporation) unless the fair price provisions and the procedural provisions of the Act are satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Business
combination&#148; is defined by the Act as (i)&nbsp;any merger, consolidation or conversion of a corporation with or into any other corporation or any unincorporated entity, (ii)&nbsp;any sale or lease of all or any substantial part of the
corporation&#146;s assets to any other entity, or (iii)&nbsp;any payment, sale or lease to the corporation or any subsidiary thereof in exchange for securities of the corporation of any assets having an aggregate fair market value equal to or
greater than $5,000,000 of any other entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Act contains provisions that allow a corporation to &#147;opt out&#148; of the applicability of the
Act&#146;s voting provisions within specified time periods that generally have expired. The Act applies to Wolfspeed since we did not opt out within these time periods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This statute could discourage a third party from making a partial tender offer or otherwise attempting to obtain a substantial position in our equity
securities or seeking to obtain control of us. It also might limit the price that certain investors might be willing to pay in the future for our shares of common stock and may have the effect of delaying or preventing a change of control of us.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_8"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following description, together with the additional information we include in any applicable prospectus supplement or free writing prospectus, summarizes
certain general terms and provisions of the debt securities that we may offer under this prospectus. When we offer to sell a particular series of debt securities, we will describe the specific terms of the series in a supplement to this prospectus.
We will also indicate in the supplement to what extent the general terms and provisions described in this prospectus apply to a particular series of debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue debt securities either separately, or together with, or upon the conversion or exercise of or in exchange for, other securities described in this
prospectus. Debt securities may be our senior, senior subordinated or subordinated obligations and, unless otherwise specified in a supplement to this prospectus, the debt securities will be our direct, unsecured obligations and may be issued in one
or more series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debt securities will be issued under an indenture between us and a third party to be identified therein, as trustee. We have
summarized select portions of the indenture below. The summary is not complete. The form of the indenture has been filed as an exhibit to the registration statement and you should read the indenture for provisions that may be important to you. In
the summary below, we have included references to the section numbers of the indenture so that you can easily locate these provisions. Capitalized terms used in the summary and not defined herein have the meanings specified in the indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in this section only, &#147;Wolfspeed,&#148; &#147;we,&#148; &#147;our&#148; or &#147;us&#148; refer to Wolfspeed, Inc. excluding our subsidiaries,
unless expressly stated or the context otherwise requires. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors and set forth or determined in the
manner provided in a resolution of our board of directors, in an officer&#146;s certificate or by a supplemental indenture. (Section 2.2) The particular terms of each series of debt securities will be described in a prospectus supplement relating to
such series (including any pricing supplement or term sheet). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We can issue an unlimited amount of debt securities under the indenture that may be in one
or more series with the same or various maturities, at par, at a premium, or at a discount. (Section 2.1) We will set forth in a prospectus supplement (including any pricing supplement or term sheet) relating to any series of debt securities being
offered, the aggregate principal amount and the following terms of the debt securities, if applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title and ranking of the debt securities (including the terms of any subordination provisions);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices (expressed as a percentage of the principal amount) at which we will sell the debt
securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit on the aggregate principal amount of the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates on which the principal of the securities of the series is payable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates
(including any commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear interest, the date or dates from which interest will accrue, the date or dates on which interest will commence and be payable
and any regular record date for the interest payable on any interest payment date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places where principal of, and interest, if any, on the debt securities will be payable (and the
method of such payment), where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and demands to us in respect of the debt securities may be delivered; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the period or periods within which, the price or prices at which and the terms and conditions upon which we may
redeem the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous
provisions or at the option of a holder of debt securities and the period or periods within which, the price or prices at which and in the terms and conditions upon which securities of the series shall be redeemed or purchased, in whole or in part,
pursuant to such obligation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dates on which and the price or prices at which we will repurchase debt securities at the option of the
holders of debt securities and other detailed terms and provisions of these repurchase obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any
integral multiple thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities will be issued in the form of certificated debt securities or global debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity
date, if other than the principal amount; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency of denomination of the debt securities, which may be United States Dollars or any foreign currency,
and if such currency of denomination is a composite currency, the agency or organization, if any, responsible for overseeing such composite currency; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation of the currency, currencies or currency units in which payment of principal of, premium and
interest on the debt securities will be made; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if payments of principal of, premium or interest on the debt securities will be made in one or more currencies or
currency units other than that or those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the manner in which the amounts of payment of principal of, premium, if any, or interest on the debt securities
will be determined, if these amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions relating to any security provided for the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any addition to, deletion of or change in the Events of Default described in this prospectus or in the indenture
with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect to the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any addition to, deletion of or change in the covenants described in this prospectus or in the indenture with
respect to the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect
to the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the provisions, if any, relating to conversion or exchange of any debt securities of such series, including if
applicable, the conversion or exchange price and period, provisions as to whether conversion or exchange will be mandatory, the events requiring an adjustment of the conversion or exchange price and provisions affecting conversion or exchange;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the debt securities, which may supplement, modify or delete any provision of the indenture as
it applies to that series, including any terms that may be required under applicable law or regulations or advisable in connection with the marketing of the securities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether any of our direct or indirect subsidiaries will guarantee the debt securities of that series, including
the terms of subordination, if any, of such guarantees. (Section 2.2) </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue debt securities that provide for an amount less than their stated principal amount to be due
and payable upon declaration of acceleration of their maturity pursuant to the terms of the indenture. We will provide you with information on the federal income tax considerations and other special considerations applicable to any of these debt
securities in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we denominate the purchase price of any of the debt securities in a foreign currency or currencies
or a foreign currency unit or units, or if the principal of and any premium and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit or units, we will provide you with information on the
restrictions, elections, general tax considerations, specific terms, and other information with respect to that issue of debt securities and such foreign currency or currencies or foreign currency unit or units in the applicable prospectus
supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer and Exchange </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each debt
security will be represented by either one or more global securities registered in the name of The Depository Trust Company (the &#147;Depositary&#148;), or a nominee of the Depositary (we will refer to any debt security represented by a global debt
security as a &#147;book-entry debt security&#148;), or a certificate issued in definitive registered form (we will refer to any debt security represented by a certificated security as a &#147;certificated debt security&#148;) as set forth in the
applicable prospectus supplement. Except as set forth under the heading &#147;Global Debt Securities and Book-Entry System&#148; below, book-entry debt securities will not be issuable in certificated form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certificated Debt Securities. You may transfer or exchange certificated debt securities at any office we maintain for this purpose in accordance with the
terms of the indenture. (Section 2.4) No service charge will be made for any transfer or exchange of certificated debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection
with a transfer or exchange. (Section 2.7) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may effect the transfer of certificated debt securities and the right to receive the principal of, premium
and interest on certificated debt securities only by surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the certificate to the new holder or the issuance by us or the trustee of
a new certificate to the new holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Global Debt Securities and Book-Entry System. Each global debt security representing book-entry debt securities will
be deposited with, or on behalf of, the Depositary, and registered in the name of the Depositary or a nominee of the Depositary. Please see &#147;Global Securities.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Covenants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will set forth in the applicable prospectus
supplement any restrictive covenants applicable to any issue of debt securities. (Article IV) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Protection in the Event of a Change of Control
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless we state otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions which may afford holders of the
debt securities protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction results in a change in control) which could adversely affect holders of debt securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, Merger and Sale of Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may not consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our properties and assets to any person (a
&#147;successor person&#148;) unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are the surviving entity or the successor person (if other than Wolfspeed) is a corporation, partnership,
trust or other entity organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly assumes our obligations on the debt securities and under the indenture; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be
continuing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the above, any of our subsidiaries may consolidate with, merge into or transfer all or part of its
properties to us. (Section 5.1) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Event of Default&#148; means with respect to any series of debt securities, any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the payment of any interest upon any debt security of that series when it becomes due and payable, and
continuance of such default for a period of 30 days (unless the entire amount of the payment is deposited by us with the trustee or with a paying agent prior to the expiration of the <FONT STYLE="white-space:nowrap">30-day</FONT> period);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the payment of principal of any security of that series at its maturity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the performance or breach of any other covenant or warranty by us in the indenture (other than a
covenant or warranty that has been included in the indenture solely for the benefit of a series of debt securities other than that series), which default continues uncured for a period of 60 days after we receive written notice from the trustee or
Wolfspeed and the trustee receive written notice from the holders of not less than 25% in principal amount of the outstanding debt securities of that series as provided in the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain voluntary or involuntary events of bankruptcy, insolvency or reorganization of Wolfspeed;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other Event of Default provided with respect to debt securities of that series that is described in the
applicable prospectus supplement. (Section 6.1) </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No Event of Default with respect to a particular series of debt securities (except as
to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an Event of Default with respect to any other series of debt securities. (Section 6.1) The occurrence of certain Events of Default or an acceleration under the
indenture may constitute an event of default under certain indebtedness of ours or our subsidiaries outstanding from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will provide the
trustee written notice of any Default or Event of Default within 30 days of becoming aware of the occurrence of such Default or Event of Default, which notice will describe in reasonable detail the status of such Default or Event of Default and what
action we are taking or propose to take in respect thereof. (Section&nbsp;6.1) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an Event of Default with respect to debt securities of any series at
the time outstanding occurs and is continuing, then the trustee or the holders of not less than 25% in principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders),
declare to be due and payable immediately the principal of (or, if the debt securities of that series are discount securities, that portion of the principal amount as may be specified in the terms of that series) and accrued and unpaid interest, if
any, on all debt securities of that series. In the case of an Event of Default resulting from certain events of bankruptcy, insolvency or reorganization, the principal (or such specified amount) of and accrued and unpaid interest, if any, on all
outstanding debt securities will become and be immediately due and payable without any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
declaration or other act on the part of the trustee or any holder of outstanding debt securities. At any time after a declaration of acceleration with respect to debt securities of any series has
been made, but before a judgment or decree for payment of the money due has been obtained by the trustee, the holders of a majority in principal amount of the outstanding debt securities of that series may rescind and annul the acceleration if all
Events of Default, other than the <FONT STYLE="white-space:nowrap">non-payment</FONT> of accelerated principal and interest, if any, with respect to debt securities of that series, have been cured or waived as provided in the indenture. (Section
6.2) We refer you to the prospectus supplement relating to any series of debt securities that are discount securities for the particular provisions relating to acceleration of a portion of the principal amount of such discount securities upon the
occurrence of an Event of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture provides that the trustee may refuse to perform any duty or exercise any of its rights or powers under
the indenture unless the trustee receives indemnity satisfactory to it against any cost, liability or expense which might be incurred by it in performing such duty or exercising such right or power. (Section 7.1(e)) Subject to certain rights of the
trustee, the holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any
trust or power conferred on the trustee with respect to the debt securities of that series. (Section 6.12) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No holder of any debt security of any series
will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the appointment of a receiver or trustee, or for any remedy under the indenture, unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that holder has previously given to the trustee written notice of a continuing Event of Default with respect to
debt securities of that series; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holders of not less than 25% in principal amount of the outstanding debt securities of that series have made
written request, and offered indemnity or security satisfactory to the trustee, to the trustee to institute the proceeding as trustee, and the trustee has not received from the holders of not less than a majority in principal amount of the
outstanding debt securities of that series a direction inconsistent with that request and has failed to institute the proceeding within 60 days. (Section 6.7) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision in the indenture, the holder of any debt security will have an absolute and unconditional right to receive payment of the
principal of, premium and any interest on that debt security on or after the due dates expressed in that debt security and to institute suit for the enforcement of payment. (Section&nbsp;6.8) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture requires us, within 120 days after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture.
(Section 4.3) If a Default or Event of Default occurs and is continuing with respect to the securities of any series and if it is known to a responsible officer of the trustee, the trustee shall mail to each Securityholder of the securities of that
series notice of a Default or Event of Default within 90 days after it occurs or, if later, after a responsible officer of the trustee has knowledge of such Default or Event of Default. The indenture provides that the trustee may withhold notice to
the holders of debt securities of any series of any Default or Event of Default (except in payment on any debt securities of that series) with respect to debt securities of that series if the trustee determines in good faith that withholding notice
is in the interest of the holders of those debt securities. (Section 7.5) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and the trustee may modify, amend or supplement the indenture or the debt securities of any series without the consent of any holder of any debt security:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to cure any ambiguity, defect or inconsistency; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to comply with covenants in the indenture described above under the heading &#147;Consolidation, Merger and Sale
of Assets&#148;; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to provide for uncertificated securities in addition to or in place of certificated securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add guarantees with respect to debt securities of any series or secure debt securities of any series;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to surrender any of our rights or powers under the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add covenants or events of default for the benefit of the holders of debt securities of any series;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to comply with the applicable procedures of the applicable depositary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to make any change that does not adversely affect the rights of any holder of debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to provide for the issuance of and establish the form and terms and conditions of debt securities of any series
as permitted by the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to effect the appointment of a successor trustee with respect to the debt securities of any series and to add to
or change any of the provisions of the indenture to provide for or facilitate administration by more than one trustee; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under
the Trust Indenture Act. (Section 9.1) </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also modify and amend the indenture with the consent of the holders of at least a
majority in principal amount of the outstanding debt securities of each series affected by the modifications or amendments. We may not make any modification or amendment without the consent of the holders of each affected debt security then
outstanding if that amendment will: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the amount of debt securities whose holders must consent to an amendment, supplement or waiver;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the rate of or extend the time for payment of interest (including default interest) on any debt security;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal of or premium on or change the fixed maturity of any debt security or reduce the amount of,
or postpone the date fixed for, the payment of any sinking fund or analogous obligation with respect to any series of debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal amount of discount securities payable upon acceleration of maturity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive a default in the payment of the principal of, premium or interest on any debt security (except a rescission
of acceleration of the debt securities of any series by the holders of at least a majority in aggregate principal amount of the then outstanding debt securities of that series and a waiver of the payment default that resulted from such
acceleration); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make the principal of or premium or interest on any debt security payable in currency other than that stated in
the debt security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change to certain provisions of the indenture relating to, among other things, the right of holders of
debt securities to receive payment of the principal of, premium and interest on those debt securities and to institute suit for the enforcement of any such payment and to waivers or amendments; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive a redemption payment with respect to any debt security. (Section 9.3) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for certain specified provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series may on behalf
of the holders of all debt securities of that series waive our compliance with provisions of the indenture. (Section 9.2) The holders of a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of
all the debt securities of such series waive any past default under the indenture with respect to that series and its consequences, except a default in the payment of the principal of, premium or any interest on any debt security of that series;
provided, however, that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the holders of a majority in principal amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related payment default that
resulted from the acceleration. (Section 6.13) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Defeasance of Debt Securities and Certain Covenants in Certain Circumstances </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Legal Defeasance</I>. The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, we may be discharged
from any and all obligations in respect of the debt securities of any series (subject to certain exceptions). We will be so discharged upon the irrevocable deposit with the trustee, in trust, of money and/or U.S. government obligations or, in the
case of debt securities denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their
terms, will provide money or U.S. government obligations in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal, premium and
interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discharge may occur only if, among other things, we have delivered to the trustee an opinion of counsel stating that we have received from, or there has
been published by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change in the applicable United States federal income tax law, in either case to the effect that, and based
thereon such opinion shall confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit, defeasance and discharge and will be subject
to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit, defeasance and discharge had not occurred. (Section 8.3) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Defeasance of Certain Covenants</I>. The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, upon
compliance with certain conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may omit to comply with the covenant described under the heading &#147;Consolidation, Merger and Sale of
Assets&#148; and certain other covenants set forth in the indenture, as well as any additional covenants which may be set forth in the applicable prospectus supplement; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any omission to comply with those covenants will not constitute a Default or an Event of Default with respect to
the debt securities of that series (&#147;covenant defeasance&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conditions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">depositing with the trustee money and/or U.S. government obligations or, in the case of debt securities
denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide
money in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal of, premium and interest on, and any mandatory sinking fund payments
in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering to the trustee an opinion of counsel to the effect that the holders of the debt securities of that
series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit and related covenant defeasance and will be subject to United States federal income tax on the same amounts and in the same
manner and at the same times as would have been the case if the deposit and related covenant defeasance had not occurred. (Section 8.4) </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Personal Liability of Directors, Officers, Employees or Securityholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of our past, present or future directors, officers, employees or securityholders, as such, will have any liability for any of our obligations under the
debt securities or the indenture or for any claim based on, or in respect or by reason of, such obligations or their creation. By accepting a debt security, each holder waives and releases all such liability. This waiver and release is part of the
consideration for the issue of the debt securities. However, this waiver and release may not be effective to waive liabilities under U.S. federal securities laws, and it is the view of the SEC that such a waiver is against public policy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture and the debt securities,
including any claim or controversy arising out of or relating to the indenture or the securities, will be governed by the laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture will provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably waive, to the
fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to the indenture, the debt securities or the transactions contemplated thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture will provide that any legal suit, action or proceeding arising out of or based upon the indenture or the transactions contemplated thereby may
be instituted in the federal courts of the United States of America located in the City of New York or the courts of the State of New York in each case located in the City of New York, and we, the trustee and the holder of the debt securities (by
their acceptance of the debt securities) irrevocably submit to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of such courts in any such suit, action or proceeding. The indenture will further provide that service of any
process, summons, notice or document by mail (to the extent allowed under any applicable statute or rule of court) to such party&#146;s address set forth in the indenture will be effective service of process for any suit, action or other proceeding
brought in any such court. The indenture will further provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably and unconditionally waive any objection to the laying of venue of any
suit, action or other proceeding in the courts specified above and irrevocably and unconditionally waive and agree not to plead or claim any such suit, action or other proceeding has been brought in an inconvenient forum. (Section 10.10) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_9"></A>DESCRIPTION OF OTHER SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will set forth in the applicable prospectus supplement a description of any warrants, purchase contracts, or units issued by us that may be offered and
sold pursuant to this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_10"></A>GLOBAL SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Book-Entry, Delivery, and Form </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless we indicate
differently in any applicable prospectus supplement or free writing prospectus, the securities initially will be issued in book-entry form and represented by one or more global notes or global securities (collectively, &#147;global
securities&#148;). The global securities will be deposited with, or on behalf of, The Depository Trust Company, New York, New York, as depositary (&#147;DTC&#148;), and registered in the name of Cede&nbsp;&amp; Co., the nominee of DTC. Unless and
until it is exchanged for individual certificates evidencing securities under the limited circumstances described below, a global security may not be transferred except as a whole by the depositary to its nominee or by the nominee to the depositary,
or by the depositary or its nominee to a successor depositary or to a nominee of the successor depositary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC has advised us that it is: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited-purpose trust company organized under the New York Banking Law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;banking organization&#148; within the meaning of the New York Banking Law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a member of the Federal Reserve System; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;clearing corporation&#148; within the meaning of the New York Uniform Commercial Code; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;clearing agency&#148; registered pursuant to the provisions of Section&nbsp;17A of the Exchange Act.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC holds securities that its participants deposit with DTC. DTC also facilitates the settlement among its participants of securities
transactions, such as transfers and pledges, in deposited securities through electronic computerized book-entry changes in participants&#146; accounts, thereby eliminating the need for physical movement of securities certificates. &#147;Direct
participants&#148; in DTC include securities brokers and dealers, including underwriters, banks, trust companies, clearing corporations, and other organizations. DTC is a wholly-owned subsidiary of The Depository Trust&nbsp;&amp; Clearing
Corporation (&#147;DTCC&#148;). DTCC is the holding company for DTC, National Securities Clearing Corporation, and Fixed Income Clearing Corporation, all of which are registered clearing agencies. DTCC is owned by the users of its regulated
subsidiaries. Access to the DTC system is also available to others, which we sometimes refer to as indirect participants, that clear through or maintain a custodial relationship with a direct participant, either directly or indirectly. The rules
applicable to DTC and its participants are on file with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Purchases of securities under the DTC system must be made by or through direct
participants, which will receive a credit for the securities on DTC&#146;s records. The ownership interest of the actual purchaser of a security, which we sometimes refer to as a beneficial owner, is in turn recorded on the direct and indirect
participants&#146; records. Beneficial owners of securities will not receive written confirmation from DTC of their purchases. However, beneficial owners are expected to receive written confirmations providing details of their transactions, as well
as periodic statements of their holdings, from the direct or indirect participants through which they purchased securities. Transfers of ownership interests in global securities are to be accomplished by entries made on the books of participants
acting on behalf of beneficial owners. Beneficial owners will not receive certificates representing their ownership interests in the global securities, except under the limited circumstances described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To facilitate subsequent transfers, all global securities deposited by direct participants with DTC will be registered in the name of DTC&#146;s partnership
nominee, Cede&nbsp;&amp; Co., or such other name as may be requested by an authorized representative of DTC. The deposit of securities with DTC and their registration in the name of Cede&nbsp;&amp; Co. or such other nominee will not change the
beneficial ownership of the securities. DTC has no knowledge of the actual beneficial owners of the securities. DTC&#146;s records reflect only the identity of the direct participants to whose accounts the securities are credited, which may or may
not be the beneficial owners. The participants are responsible for keeping account of their holdings on behalf of their customers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">So long as the securities are in book-entry form, you will receive payments and may transfer securities only
through the facilities of the depositary and its direct and indirect participants. We will maintain an office or agency in the location specified in the prospectus supplement for the applicable securities, where notices and demands in respect of the
securities and the indenture may be delivered to us and where certificated securities may be surrendered for payment, registration of transfer, or exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Conveyance of notices and other communications by DTC to direct participants, by direct participants to indirect participants, and by direct participants and
indirect participants to beneficial owners will be governed by arrangements among them, subject to any legal requirements in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redemption notices will be sent to DTC. If less than all of the securities of a particular series are being redeemed, DTC&#146;s practice is to determine by
lot the amount of the interest of each direct participant in the securities of such series to be redeemed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither DTC nor Cede&nbsp;&amp; Co. (or such
other DTC nominee) will consent or vote with respect to the securities. Under its usual procedures, DTC will mail an omnibus proxy to us as soon as possible after the record date. The omnibus proxy assigns the consenting or voting rights of
Cede&nbsp;&amp; Co. to those direct participants to whose accounts the securities of such series are credited on the record date, identified in a listing attached to the omnibus proxy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">So long as securities are in book-entry form, we will make payments on those securities to the depositary or its nominee, as the registered owner of such
securities, by wire transfer of immediately available funds. If securities are issued in definitive certificated form under the limited circumstances described below and unless if otherwise provided in the description of the applicable securities
herein or in the applicable prospectus supplement, we will have the option of making payments by check mailed to the addresses of the persons entitled to payment or by wire transfer to bank accounts in the United States designated in writing to the
applicable trustee or other designated party at least 15 days before the applicable payment date by the persons entitled to payment, unless a shorter period is satisfactory to the applicable trustee or other designated party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redemption proceeds, distributions, and dividend payments on the securities will be made to Cede&nbsp;&amp; Co., or such other nominee as may be requested by
an authorized representative of DTC. DTC&#146;s practice is to credit direct participants&#146; accounts upon DTC&#146;s receipt of funds and corresponding detail information from us on the payment date in accordance with their respective holdings
shown on DTC records. Payments by participants to beneficial owners will be governed by standing instructions and customary practices, as is the case with securities held for the account of customers in bearer form or registered in &#147;street
name.&#148; Those payments will be the responsibility of participants and not of DTC or us, subject to any statutory or regulatory requirements in effect from time to time. Payment of redemption proceeds, distributions, and dividend payments to
Cede&nbsp;&amp; Co., or such other nominee as may be requested by an authorized representative of DTC, is our responsibility, disbursement of payments to direct participants is the responsibility of DTC, and disbursement of payments to the
beneficial owners is the responsibility of direct and indirect participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except under the limited circumstances described below, purchasers of
securities will not be entitled to have securities registered in their names and will not receive physical delivery of securities. Accordingly, each beneficial owner must rely on the procedures of DTC and its participants to exercise any rights
under the securities and the indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The laws of some jurisdictions may require that some purchasers of securities take physical delivery of
securities in definitive form. Those laws may impair the ability to transfer or pledge beneficial interests in securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC may discontinue providing
its services as securities depositary with respect to the securities at any time by giving reasonable notice to us. Under such circumstances, in the event that a successor depositary is not obtained, securities certificates are required to be
printed and delivered. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As noted above, beneficial owners of a particular series of securities generally will not receive
certificates representing their ownership interests in those securities. However, if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DTC notifies us that it is unwilling or unable to continue as a depositary for the global security or securities
representing such series of securities or if DTC ceases to be a clearing agency registered under the Exchange Act at a time when it is required to be registered and a successor depositary is not appointed within 90 days of the notification to us or
of our becoming aware of DTC&#146;s ceasing to be so registered, as the case may be; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we determine, in our sole discretion, not to have such securities represented by one or more global securities;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an Event of Default has occurred and is continuing with respect to such series of securities,
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">we will prepare and deliver certificates for such securities in exchange for beneficial interests in the global securities. Any
beneficial interest in a global security that is exchangeable under the circumstances described in the preceding sentence will be exchangeable for securities in definitive certificated form registered in the names that the depositary directs. It is
expected that these directions will be based upon directions received by the depositary from its participants with respect to ownership of beneficial interests in the global securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Euroclear and Clearstream </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If so
provided in the applicable prospectus supplement, you may hold interests in a global security through Clearstream Banking S.A., which we refer to as &#147;Clearstream,&#148; or Euroclear Bank S.A./N.V., as operator of the Euroclear System, which we
refer to as &#147;Euroclear,&#148; either directly if you are a participant in Clearstream or Euroclear or indirectly through organizations which are participants in Clearstream or Euroclear. Clearstream and Euroclear will hold interests on behalf
of their respective participants through customers&#146; securities accounts in the names of Clearstream and Euroclear, respectively, on the books of their respective U.S. depositaries, which in turn will hold such interests in customers&#146;
securities accounts in such depositaries&#146; names on DTC&#146;s books. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clearstream and Euroclear are securities clearance systems in Europe.
Clearstream and Euroclear hold securities for their respective participating organizations and facilitate the clearance and settlement of securities transactions between those participants through electronic book-entry changes in their accounts,
thereby eliminating the need for physical movement of certificates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payments, deliveries, transfers, exchanges, notices, and other matters relating to
beneficial interests in global securities owned through Euroclear or Clearstream must comply with the rules and procedures of those systems. Transactions between participants in Euroclear or Clearstream, on one hand, and other participants in DTC,
on the other hand, are also subject to DTC&#146;s rules and procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors will be able to make and receive through Euroclear and Clearstream
payments, deliveries, transfers, and other transactions involving any beneficial interests in global securities held through those systems only on days when those systems are open for business. Those systems may not be open for business on days when
banks, brokers and other institutions are open for business in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cross-market transfers between participants in DTC, on the one hand,
and participants in Euroclear or Clearstream, on the other hand, will be effected through DTC in accordance with the DTC&#146;s rules on behalf of Euroclear or Clearstream, as the case may be, by their respective U.S. depositaries; however, such
cross-market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (European time) of
such system. Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its U.S. depositary to take action to effect final settlement on its behalf by delivering or receiving
interests in the global securities through DTC, and making or receiving payment in accordance with normal procedures for <FONT STYLE="white-space:nowrap">same-day</FONT> fund settlement. Participants in Euroclear or Clearstream may not deliver
instructions directly to their respective U.S. depositaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to time zone differences, the securities accounts of a participant in Euroclear or Clearstream
purchasing an interest in a global security from a direct participant in DTC will be credited, and any such crediting will be reported to the relevant participant in Euroclear or Clearstream, during the securities settlement processing day (which
must be a business day for Euroclear or Clearstream) immediately following the settlement date of DTC. Cash received in Euroclear or Clearstream as a result of sales of interests in a global security by or through a participant in Euroclear or
Clearstream to a direct participant in DTC will be received with value on the settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or Clearstream following
DTC&#146;s settlement date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Other </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this section of this prospectus concerning DTC, Clearstream, Euroclear, and their respective book-entry systems has been obtained from
sources that we believe to be reliable, but we do not take responsibility for this information. This information has been provided solely as a matter of convenience. The rules and procedures of DTC, Clearstream, and Euroclear are solely within the
control of those organizations and could change at any time. Neither we nor the trustee nor any agent of ours or of the trustee has any control over those entities and none of us takes any responsibility for their activities. You are urged to
contact DTC, Clearstream, and Euroclear or their respective participants directly to discuss those matters. In addition, although we expect that DTC, Clearstream, and Euroclear will perform the foregoing procedures, none of them is under any
obligation to perform or continue to perform such procedures and such procedures may be discontinued at any time. Neither we nor any agent of ours will have any responsibility for the performance or nonperformance by DTC, Clearstream, and Euroclear
or their respective participants of these or any other rules or procedures governing their respective operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_11"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may sell the offered securities from time to time: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through underwriters or dealers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through agents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to one or more purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through sales &#147;at the market&#148; to or through a market maker or into an existing trading market for the
common stock; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through a combination of any of these methods of sale. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will identify the specific plan of distribution, including any underwriters, dealers, agents or direct purchasers and their compensation in the applicable
prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_12"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Smith, Anderson, Blount, Dorsett, Mitchell&nbsp;&amp; Jernigan, LLP and Latham&nbsp;&amp; Watkins LLP will pass upon certain legal matters relating to the
issuance and sale of the securities offered hereby on behalf of Wolfspeed, Inc. Additional legal matters may be passed upon for us, or any underwriters, dealers, or agents, by counsel that we will name in the applicable prospectus supplement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc737660_13"></A>EXPERTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
financial statements and management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included in Management&#146;s Report on Internal Control over Financial Reporting) incorporated in this Prospectus by
reference to the Annual Report on Form 10-K for the year ended June 30, 2024 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as
experts in auditing and accounting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:28pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Up to </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>$200,000,000 </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B><I>Common
Stock </I></B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g840767g40e50.jpg" ALT="LOGO" STYLE="width:1.93218in;height:0.62715in;">
 </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>J.P. Morgan </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Wells
Fargo Securities </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>December 9, 2024 </B></P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>d840767dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:wolf="http://www.wolfspeed.com/20241209" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:srt="http://fasb.org/srt/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31">
<head>
<title>EX-FILING FEES</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;">

 <div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P12_09_2024To12_09_2024" id="ixv-280">0000895419</ix:nonNumeric><ix:nonNumeric name="ffd:SubmissnTp" id="hidden127684477" contextRef="P12_09_2024To12_09_2024">424B5</ix:nonNumeric><ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="P12_09_2024To12_09_2024" id="ixv-282">EX-FILING FEES</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"/></ix:references><ix:resources><xbrli:context id="P12_09_2024To12_09_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000895419</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-12-09</xbrli:startDate> <xbrli:endDate>2024-12-09</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000895419</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>1</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-12-09</xbrli:startDate> <xbrli:endDate>2024-12-09</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit></ix:resources></ix:header></div><div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right;"><div style="font-weight:bold;display:inline;">Exhibit 107.1 </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Calculation of Filing Fee Tables </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;display:inline;"><div style="-sec-ix-hidden:hidden127684477;display:inline;">424(b)(5)</div> </div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Form Type) </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P12_09_2024To12_09_2024" id="ixv-305">Wolfspeed, Inc.</ix:nonNumeric> </div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Exact Name of Registrant as Specified in its Charter) </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;display:inline;">Table 1: Newly Registered and Carry Forward Securities </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:5%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:8%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:6%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:6%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:6%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:11%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:9%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:9%"/></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">Security<br/>Type</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">Security<br/>Class&#160;Title</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">Fee<br/>Calculation<br/>Rule</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">Amount<br/>Registered</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">Proposed<br/>Maximum&#8201;<br/>Offering<br/>Price Per<br/>Unit</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">Maximum<br/>Aggregate Offering<br/>Price</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">Fee Rate</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;text-align:center;">Amount of<br/>Registration<br/>Fee</td></tr>
<tr style="font-size:1pt">
<td colspan="17" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="17" style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:top;text-align:center;">Newly Registered Securities</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis" format="ixt:fixed-false" id="ixv-104">Fees to Be<br/>Paid</ix:nonNumeric></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis" id="ixv-306">Equity</ix:nonNumeric></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis" id="ixv-110">Common<br/>Stock, par value<br/>$0.00125<br/>per share</ix:nonNumeric>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis" format="ixt:fixed-true" id="ixv-307">Rule 457(o)</ix:nonNumeric><div style="font-size:75%; vertical-align:top;display:inline;font-size:8.3px"> (1)</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-308">200,000,000</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:FeeRate" contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-309">0.00015310</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:FeeAmt" contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-310">30,620.00</ix:nonFraction></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="font-size:1px; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;">Fees<br/>Previously<br/>Paid</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;&#8194;</td></tr>
<tr style="font-size:1pt">
<td colspan="17" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="17" style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:top;text-align:center;">Carry Forward Securities</td></tr>
<tr style="font-size:1pt">
<td colspan="17" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="17" style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:top;text-align:center;">N/A</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">Total Offering Amounts</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="P12_09_2024To12_09_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-311">200,000,000</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TtlFeeAmt" contextRef="P12_09_2024To12_09_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-312">30,620.00</ix:nonFraction>&#8201;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">Total Fees Previously Paid</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="P12_09_2024To12_09_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero" id="ixv-313">&#8212;</ix:nonFraction></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">Total Fee Offsets</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="P12_09_2024To12_09_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero" id="ixv-314">&#8212;</ix:nonFraction></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">Net Fee Due</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:NetFeeAmt" contextRef="P12_09_2024To12_09_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-315">30,620.00</ix:nonFraction></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><ix:nonNumeric name="ffd:OfferingNote" contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis" escape="true" id="ixv-270">
<table style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), based on the proposed maximum aggregate offering price, and Rule 457(r) under the Securities Act. In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant initially deferred payment of all of the registration fee for Registration Statement on Form <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="ffd:FormTp" contextRef="P12_09_2024To12_09_2024" id="ixv-316">S-3</ix:nonNumeric></div> (File <div style="white-space:nowrap;display:inline;">No.&#160;<ix:nonNumeric name="ffd:RegnFileNb" contextRef="P12_09_2024To12_09_2024" id="ixv-317">333-283676</ix:nonNumeric>),</div> filed by the registrant with the Securities and Exchange Commission on December&#160;9, 2024. </div></td></tr></table> </ix:nonNumeric></div></div></div></div></div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g737660g24g51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g737660g24g51.jpg
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M  (1 Q$ /P#5-*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E*
M4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%4)J+:3J;0.N+A;;NENZVQ3G/,!P!M
M8:421NJ [.(X@\1V5?=5+RBM+?2^ET7B*WF7;,E>!Q4R?M>XX/EO5ITKAOVS
M64R=>,X9)=';3=-ZHW&HTP19JO\ PLK"%D]R3U*]#GPJ:U@BI[HW:MJ736XS
MTGZ0@IX='EDJP/PJZQ\O"MEOIWFMELJ/\35&I8DR;8IK%KE+B3RC>CO)/V7!
MQ3GP) !'<34!V;;58M^>%HU"E%NOS:BT4J]EMY0."!G[*L_=/IW5Z=&[8--Z
MAW&93QM4Y7#FI2@$$_A<ZO?@^%5GMYT)-8U [J"RPW7[?+2'7U,)WN:<[5$#
ML/ Y[\U132FW5:L/PR$8_ID:3I6<=ENV5^V\S:]6+<D0AA+<S[3C0[E]JD^/
M6/&M$0Y3$V*U)AO-OQW4A2'&U!25 ]H(K/=1.EXD0E!Q[GVI2E4D12E* 4I2
M@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E
M* 4I2@%*4H!2E* 4I2@%*4) ZR!0"E?)R0RW_$>;3^90%>=R[VUO^)<(:/S/
M)'[UW#8/;7XD,MR([K#Z$N-.)*%H4,A22,$&N8YJ6Q-_Q+U;$?FE-C]Z\SFM
M-,-_;U'9QX=-;S_NKJA+PCN&9(V@:<<TKJR?:UA1:;7O,+/WVE<4GW<#X@U'
M:O;E"2]-7ZV0KC:;Q;Y-SBKYI3;+H6IQI6>[N/'U-437T6GL=E:<NYM@\K+%
M2W1^T+46E%)1;9RG(@ZXLCVVO0=:?0BIAL-L>FM61;G9;] 2N>V>D,/H6I#A
M0<)4,@]AP>.?M&I)?^3\RK>78+RML]C4Q&\/ZTXQ_2:JLU%6YUVHC*<<[9'%
M%^V?:]]G44$Z<O"__&1S]6M7>3C']0_577L5EUELW7TO3[C>IM,NG?6S'5DE
M/\R4\<'Q3O ]M5U?]E6KK+O*<M3DME/_ 'D,\\#Z#VO>*Y&G-5:@TC+5]%S9
M$0A7UD=8RA1_$@\,^/74>DIQQ5+*]GRO^HYMROA9KK26J;9JFWF3:WCOH.Z]
M'<&ZZRK^5:>SY&NY5":2VNZ?GW6/+U3:DV^[(&[](Q K=6.K"P/:W? [P[>%
M7C;+E"NL1$JVRV)4=74XRL*3[QVUY-],JGRL+[\F>47$]5*4J@@*4I0"E*4
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M>U%-I&M(NB;"9KZ.>E.JYN,QG'.*[R>Q([3Y=]2NLO<I"[+FZ[1!"OJH$="
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MM#URD5*JA>V::F#LTOJU8RXR& #VE:@G]ZR4YZD<>Z*X]T8[K5NVC4SMDV;
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)%*4H!2E* __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g840767g24g51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g840767g24g51.jpg
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M  (1 Q$ /P#5-*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E*
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M7C;+E"NL1$JVRV)4=74XRL*3[QVUY-],JGRL+[\F>47$]5*4J@@*4I0"E*4
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M>U%-I&M(NB;"9KZ.>E.JYN,QG'.*[R>Q([3Y=]2NLO<I"[+FZ[1!"OJH$="
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MM#URD5*JA>V::F#LTOJU8RXR& #VE:@G]ZR4YZD<>Z*X]T8[K5NVC4SMDV;
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)%*4H!2E* __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g840767g40e50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g840767g40e50.jpg
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MLL(D0U.BT42#TA<8-%1C<Y.4P_ E155D=.'B_\0 &@$!  ,! 0$
M      (#! $%!O_$ #$1  (" 0(% @,( P$!       ! @,1!"$%$A,Q42)!
M%#)A(T)2<8&1H;$5,_#!X?_:  P# 0 "$0,1 #\ M2B(@"(B (B( B(@"(B
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M (B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (B(
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M(B*HB$1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1
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MN+^AW:+G=%5<E125<4E]I[X::;FO2881&0< [KB"6N<,]+<=ZZ)42CRO!%K
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MYA0$1:K5=YAT]IRX76HQN4L)> ?K.Z&M\R0/-=2;>$%N9\]53P.#9YXHW$9
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M*I;=JMPRV*E<"T>T_H'ED]RBFEONKMKVH!:F5)H;3\^HCI\MCCCSTN/2\GH
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MCM-,QGJ@2S$#G)G#ZSCU^'0.I;U9Y\2>?0MB#O\ "**W.T7&UO#+G05=&XG
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M<&LJ(H!Y.WS_ "+E,>:R,?J(K+2*I*QG)>MK&6*[W-T;>=EJ13M>0,AK6@D
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MN]WK+C5NWIZJ5TK^XDYP.X="W%'J62DT%7Z?A<X>FUC)Y>S<:WH\W!I_"N;
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ME-7)HTSZ9>JS4%1'F&B',0$C@97#UB/!I_SJ&8(I)YHX86.DED<&L8T9+B>
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M@UI<X@-'$D] 5"6DM(+201T$+WFK*F=@;/4S2-'4]Y(^*HEPU-^F6Q!T>&7
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ME%1%_P \T\#8R[QP.*V*(C;>[ 7E#300O<^&"*-[OG.:P GQ7JBX B(@"(B
M(B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B
M(@*\<J.OW[M8[>'?10R3N&?MN#1_(5"5/$^>>.&(%TDC@QH'62<!6[UGLPL>
MKKP+E=IJ\3B)L0$,K6M#021@%I[2O#3&R32^GKG%<*>&IJ:F([T1JI \,=U.
M   SXY7L4ZF%5*6#3&Q1B=Q;:5M#;J6D9\R")D0\&C'Z+(1%XYF"(B (B( B
K(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (B(#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46451357024800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Dec. 09, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000895419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Wolfspeed, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46451356912464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Dec. 09, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">CommonStock, par value$0.00125per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 30,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), based on the proposed maximum aggregate offering price, and Rule 457(r) under the Securities Act. In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant initially deferred payment of all of the registration fee for Registration Statement on Form <div style="white-space:nowrap;display:inline;">S-3</div> (File <div style="white-space:nowrap;display:inline;">No.&#160;333-283676),</div> filed by the registrant with the Securities and Exchange Commission on December&#160;9, 2024. </div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46451357077872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Dec. 09, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">30,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 30,620<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !<08E9C)=H*&4"  #%!@  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V5T6[:,!2&7\7*I%VU)"0A4 :11@L;6H=0V=9)TRY,<B!6[3BS38&WG^U
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M>RY(DX#KN1#Z$)@^,'3QY!]02P,$%     @ 7$&)61=!858$ P  <0\   T
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MO]%M:9V[5>TY/)(MQT48EWCU#5!+ P04    " !<08E9NVSJ[+H    : P
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
M7$&)6?NCIOGO    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ 7$&)69E<G",0!@  G"<  !,
M ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !<08E9C)=H
M*&4"  #%!@  &               @($."   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ 7$&)6=::JOYX P  APD  !@
M ("!J0H  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( %Q!
MB5EG ZBF-P(  -$%   8              " @5<.  !X;"]W;W)K<VAE971S
M+W-H965T,RYX;6Q02P$"% ,4    " !<08E9%T%A5@0#  !Q#P  #0
M        @ '$$   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( %Q!B5F7BKL<
MP    !,"   +              "  ?,3  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( %Q!B5E2<6^U70$  $@#   /              "  =P4  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " !<08E9NVSJ[+H    : P  &@
M    @ %F%@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" !<08E9IOQ*6R,!  #?!   $P              @ %8%P  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "P + ,H"  "L&      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="d840767dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d840767dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d840767dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="d840767dexfilingfees.htm">d840767dexfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d840767dexfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "d840767dexfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/ffd/2024q2": 2,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 17,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P12_09_2024To12_09_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840767dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P12_09_2024To12_09_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840767dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840767dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840767dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "P12_09_2024To12_09_2024",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840767dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P12_09_2024To12_09_2024",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840767dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-24-272928-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-272928-xbrl.zip
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M?W-GF%_U^E=A.FU_]EU!%.R1CA]5LZ8K+1W^U>J58Z/>U#+$\FF#S5H/P\Z
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M3;S8#9[$F^%:_P=02P$"% ,4    " !<08E95)W>V)P+   J<P  &
M        @ $     9#@T,#<V-V1E>&9I;&EN9V9E97,N:'1M4$L%!@     !
-  $ 1@   -(+      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d840767dexfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="P12_09_2024To12_09_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000895419</identifier>
        </entity>
        <period>
            <startDate>2024-12-09</startDate>
            <endDate>2024-12-09</endDate>
        </period>
    </context>
    <context id="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000895419</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-09</startDate>
            <endDate>2024-12-09</endDate>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="P12_09_2024To12_09_2024" id="ixv-280">0000895419</dei:EntityCentralIndexKey>
    <ffd:SubmissnTp contextRef="P12_09_2024To12_09_2024" id="hidden127684477">424B5</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="P12_09_2024To12_09_2024" id="ixv-282">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityRegistrantName contextRef="P12_09_2024To12_09_2024" id="ixv-305">Wolfspeed, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg
      contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis"
      id="ixv-104">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis"
      id="ixv-306">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis"
      id="ixv-110">CommonStock, par value$0.00125per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg
      contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis"
      id="ixv-307">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-308"
      unitRef="Unit_USD">200000000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis"
      decimals="INF"
      id="ixv-309"
      unitRef="Unit_pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis"
      decimals="2"
      id="ixv-310"
      unitRef="Unit_USD">30620</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="P12_09_2024To12_09_2024"
      decimals="0"
      id="ixv-311"
      unitRef="Unit_USD">200000000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="P12_09_2024To12_09_2024"
      decimals="2"
      id="ixv-312"
      unitRef="Unit_USD">30620</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="P12_09_2024To12_09_2024"
      decimals="0"
      id="ixv-313"
      unitRef="Unit_USD">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="P12_09_2024To12_09_2024"
      decimals="0"
      id="ixv-314"
      unitRef="Unit_USD">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="P12_09_2024To12_09_2024"
      decimals="2"
      id="ixv-315"
      unitRef="Unit_USD">30620</ffd:NetFeeAmt>
    <ffd:OfferingNote
      contextRef="P12_09_2024To12_09_2024_1TypedMemberffdOfferingAxis"
      id="ixv-270">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), based on the proposed maximum aggregate offering price, and Rule 457(r) under the Securities Act. In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant initially deferred payment of all of the registration fee for Registration Statement on Form &lt;div style="white-space:nowrap;display:inline;"&gt;S-3&lt;/div&gt; (File &lt;div style="white-space:nowrap;display:inline;"&gt;No.&#160;333-283676),&lt;/div&gt; filed by the registrant with the Securities and Exchange Commission on December&#160;9, 2024. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </ffd:OfferingNote>
    <ffd:FormTp contextRef="P12_09_2024To12_09_2024" id="ixv-316">S-3</ffd:FormTp>
    <ffd:RegnFileNb contextRef="P12_09_2024To12_09_2024" id="ixv-317">333-283676</ffd:RegnFileNb>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
